Holisto (HLST) F-4 7 Sep 22 Registration of securities (foreign) Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Jun. 30, 2022
Document Information Line Items
Entity Registrant Name	Holisto Ltd.
Document Type	F-4
Amendment Flag	false
Entity Central Index Key	0001944977
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	L3
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	Sderot Nim 2
Entity Address, City or Town	Rishon Le’Zion
Entity Address, Country	IL
City Area Code	+972
Local Phone Number	72-233-6381
Contact Personnel Name	Puglisi & Associates
Business Contact
Document Information Line Items
Entity Address, Address Line One	850 Library Avenue
Entity Address, City or Town	Newark
City Area Code	(302)
Local Phone Number	738-6680
Entity Address, Address Line Two	Suite 204
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19711

Unaudited Condensed Balance She

Unaudited Condensed Balance Sheets - USD ($)		Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents			$ 2,754,000	$ 1,116,000
Short term deposit			495,000	278,000
Funds held by clearing companies			9,188,000	388,000
Other receivables and prepaid expenses			2,515,000	515,000
Financial commitment asset			203,000
Total current assets			15,155,000	2,297,000
NON – CURRENT ASSETS:
Intangible assets, net			473,000	772,000
Property and equipment, net			48,000	29,000
Total non-current assets			521,000	801,000
TOTAL ASSETS			15,676,000	3,098,000
Current maturity of long-term loan			2,105,000
Trade payables			5,602,000	690,000
Other accounts payable and accrued expenses			745,000	316,000
Advances from travellers			8,518,000	572,000
Deferred revenues			1,491,000	114,000
Total current liabilities			18,461,000	1,692,000
LONG-TERM LIABILITIES:
Long-term loan			2,985,000
SAFE			27,207,000	325,000
Warrant liability			19,346,000	383,000
Total long-term liabilities			49,538,000	708,000
COMMITMENTS AND CONTINGENCIES
Ordinary A Shares of NIS 0.01 par value – Authorized: 74,220 shares on December 31, 2021 and 2020; Issued and outstanding: 65,814 shares on December 31, 2021 and 2020			465,000	465,000
Preferred Shares of NIS 0.01 par value – Authorized: 320,978 and 304,978 shares on December 31, 2021 and 2020, respectively; Issued and outstanding: 279,723 shares on December 31, 2021 and 2020			10,000,000	10,000,000
SHAREHOLDERS’ DEFICIT:
Ordinary Shares of NIS 0.01 par value – Authorized: 604,780 and 620,780 shares on December 31, 2021 and 2020, respectively; Issued and outstanding: 119,977 shares on December 31, 2021 and 2020	[1]
Additional paid-in capital			1,290,000	827,000
Accumulated deficit			(64,078,000)	(10,594,000)
TOTAL CAPITAL DEFICIENCY			(62,788,000)	(9,767,000)
TOTAL LIABILITIES AND SHARES SUBJECT TO POSSIBLE REDEMPTION NET OF CAPITAL DEFICIENCY			15,676,000	3,098,000
Moringa Acquisition Corp
NON – CURRENT ASSETS:
Cash and cash equivalents		$ 17,803	38,944	51,701
Investments held in Trust Account		115,179,099	115,006,372
Prepaid expenses		206,353	368,853
Deferred offering costs				77,699
TOTAL ASSETS		115,403,255	115,414,169	129,400
Accrued expenses and other payables		12,165	38,576	29,400
Related party		660,000	310,000	269,990
Private warrant liability		28,804	160,341
TOTAL LIABILITIES		700,969	508,917	299,390
LONG-TERM LIABILITIES:
COMMITMENTS AND CONTINGENCIES
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION		115,179,099	115,000,000
SHAREHOLDERS’ DEFICIT:
Class A Ordinary Shares		48	48	10
Class B Ordinary Shares		288	288	288
Preferred Shares, $0.0001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of June 30, 2022 and December 31, 2021.
Preferred Shares, $0.0001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2021 and December 31, 2020.
Additional paid-in capital		676,895	855,994	25,572
Accumulated deficit		(1,154,044)	(951,078)	(195,860)
TOTAL CAPITAL DEFICIENCY		(476,813)	(94,748)	(169,990)
TOTAL LIABILITIES AND SHARES SUBJECT TO POSSIBLE REDEMPTION NET OF CAPITAL DEFICIENCY		$ 115,403,255	$ 115,414,169	$ 129,400
[1]Represents an amount less than $1.

Unaudited Condensed Balance S_2

Unaudited Condensed Balance Sheets (Parentheticals)	Jun. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 ₪ / shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2020 ₪ / shares
Preferred shares, par value (in New Shekels per share and Dollars per share) | ₪ / shares			₪ 0.01		₪ 0.01
Preferred shares, shares authorized		320,978		304,978
Preferred shares, shares issued		279,723		279,723
Preferred shares, shares outstanding		279,723		279,723
Moringa Acquisition Corp
Preferred shares, par value (in New Shekels per share and Dollars per share) | (per share)	$ 0.0001	$ 0.0001	0.0001		0.0001
Preferred shares, shares authorized	5,000,000	5,000,000		5,000,000
Preferred shares, shares issued
Preferred shares, shares outstanding
Class A Ordinary Shares
Ordinary shares, par value (in New Shekels per share and Dollars per share) | ₪ / shares			0.01		0.01
Ordinary shares, shares authorized		74,220		74,220
Ordinary shares, shares issued		65,814		65,814
Ordinary shares, shares outstanding		65,814		65,814
Class A Ordinary Shares | Moringa Acquisition Corp
Ordinary shares, par value (in New Shekels per share and Dollars per share) | (per share)	$ 0.0001	$ 0.0001	0.0001		0.0001
Ordinary shares, shares authorized	500,000,000	500,000,000		500,000,000
Ordinary shares, shares issued	480,000	480,000		100,000
Ordinary shares, shares outstanding	480,000	480,000		100,000
Ordinary shares subject to possible redemption, shares	11,500,000	11,500,000		11,500,000
Ordinary shares subject to possible redemption, redemption value (in Dollars) | $	$ 10.02	$ 10		$ 10
Ordinary Shares
Ordinary shares, par value (in New Shekels per share and Dollars per share) | ₪ / shares			0.01		0.01
Ordinary shares, shares authorized		604,780		620,780
Ordinary shares, shares issued		119,977		119,977
Ordinary shares, shares outstanding		119,977		119,977
Class B Ordinary Shares | Moringa Acquisition Corp
Ordinary shares, par value (in New Shekels per share and Dollars per share) | (per share)	$ 0.0001	$ 0.0001	₪ 0.0001		₪ 0.0001
Ordinary shares, shares authorized	50,000,000	50,000,000		50,000,000
Ordinary shares, shares issued	2,875,000	2,875,000		2,875,000
Ordinary shares, shares outstanding	2,875,000	2,875,000		2,875,000

Unaudited Condensed Statements

Unaudited Condensed Statements of Operations - USD ($)		3 Months Ended			6 Months Ended		12 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Revenues							$ 15,068,000	$ 1,204,000
Cost of revenues							4,817,000	514,000
Gross profit							10,251,000	690,000
Research and development, net							3,313,000	1,636,000
Sales and marketing							14,139,000	1,895,000
GENERAL AND ADMINISTRATIVE							2,026,000	774,000
Total operating expenses							19,478,000	4,305,000
Operating loss							9,227,000	3,615,000
Financial expenses, net							44,251,000	121,000
Loss before taxes on income							53,478,000	3,736,000
Taxes on income							6,000	5,000
Net loss							$ 53,484,000	$ 3,741,000
Net loss per share attributable to Ordinary Shares:
Basic and Diluted loss per Ordinary Share (in Dollars per share)	[1]						$ 611.33	$ 56.99
Weighted-Average shares used in computing loss per share attributable to Ordinary Shares Basic (in Shares)	[1]						87,487	65,639
NET PROFIT (LOSS) FOR THE PERIOD							$ (53,484,000)	$ (3,741,000)
Moringa Acquisition Corp
Net loss		$ (42,693)	$ 191,793	$ 195,860	$ 202,966	$ 289,547	755,218
Net loss per share attributable to Ordinary Shares:
INTEREST EARNED ON INVESTMENTS HELD IN TRUST ACCOUNT							(6,372)
GENERAL AND ADMINISTRATIVE		(156,994)	(195,061)	(195,860)	(507,230)	(287,715)	(943,933)
CHANGE IN FAIR VALUE OF PRIVATE WARRANT LIABILITY		36,346	1,520		131,537	(4,256)	182,343
NET PROFIT (LOSS) FOR THE PERIOD		42,693	(191,793)	$ (195,860)	(202,966)	(289,547)	$ (755,218)
INTEREST EARNED ON INVESTMENTS HELD IN TRUST ACCOUNT		$ 163,341	$ 1,748		$ 172,727	$ 2,424
Class A Ordinary Shares | Moringa Acquisition Corp
Net loss per share attributable to Ordinary Shares:
WEIGHTED AVERAGE NUMBER OF CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION (in Shares)		11,500,000	11,500,000	41,837	11,500,000	8,205,556	9,875,342
BASIC AND DILUTED NET PROFIT (LOSS) PER CLASS A ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION (in Dollars per share)		$ 0.01	$ (0.01)	$ (0.16)	$ (0.01)	$ (0.03)	$ (0.06)
Class B Ordinary Shares | Moringa Acquisition Corp
Net loss per share attributable to Ordinary Shares:
WEIGHTED AVERAGE NUMBER OF NON-REDEEMABLE CLASS A AND CLASS B ORDINARY SHARES (in Shares)		3,355,000	3,355,000	1,202,806	3,355,000	3,247,445	3,301,959
BASIC AND DILUTED NET LOSS PER NON-REDEEMABLE CLASS A AND CLASS B ORDINARY SHARES (in Dollars per share)		$ (0.01)	$ (0.01)	$ (0.16)	$ (0.03)	$ (0.03)	$ (0.06)
[1]see Note 15.

Unaudited Condensed Statement_2

Unaudited Condensed Statements of Operations (Parentheticals) - $ / shares	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Basic and Diluted loss per Ordinary Share						$ 611.33	$ 56.99
Weighted-Average shares used in computing loss per share attributable to Ordinary Shares Diluted (in Shares)						87,487	65,639
Class A Ordinary Shares | Moringa Acquisition Corp
Basic and Diluted loss per Ordinary Share	$ 0.01	$ (0.01)		$ (0.01)	$ (0.03)
DILUTED NET PROFIT (LOSS) PER CLASS A ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION	0.01	(0.01)	$ (0.16)	(0.01)	(0.03)	$ (0.06)
Class B Ordinary Shares | Moringa Acquisition Corp
DILUTED NET LOSS PER NON-REDEEMABLE CLASS A AND CLASS B ORDINARY SHARE	$ (0.01)	$ (0.01)	$ (0.16)	$ (0.03)	$ (0.03)	$ (0.06)

Unaudited Condensed Statement_3

Unaudited Condensed Statements of Changes in Shareholders’ Equity (Capital Deficiency) - USD ($)	Class A Moringa Acquisition Corp ordinary shares	Class A ordinary shares	Class B Moringa Acquisition Corp ordinary shares	Moringa Acquisition Corp Additional paid-in capital	Moringa Acquisition Corp Accumulated deficit	Moringa Acquisition Corp	Preferred Shares	ordinary shares		Additional paid-in capital	Accumulated deficit	Total
Balance at Dec. 31, 2019		$ 465,000					$ 9,194,000		[1]	$ 414,000	$ (6,853,000)	$ (6,439,000)
Balance (in Shares) at Dec. 31, 2019		65,814					250,056	119,977
Issuance of Preferred A Shares, net							$ 806,000
Issuance of Preferred A Shares, net (in Shares)							29,667
Share based compensation										413,000		413,000
Net Profit (Loss) for the period											(3,741,000)	(3,741,000)
Balance at Dec. 31, 2020	$ 10	$ 465,000	$ 288	$ 25,572	$ (195,860)	$ (169,990)	$ 10,000,000		[1]	827,000	(10,594,000)	(9,767,000)
Balance (in Shares) at Dec. 31, 2020	100,000	65,814	2,875,000				279,723	119,977
Balance at Sep. 23, 2020	$ 10		$ 288	25,572	(195,860)	(169,990)
Balance (in Shares) at Sep. 23, 2020	100,000		2,875,000
Net Profit (Loss) for the period					(195,860)	(195,860)
Balance at Dec. 31, 2020	$ 10	$ 465,000	$ 288	25,572	(195,860)	(169,990)	$ 10,000,000		[1]	827,000	(10,594,000)	(9,767,000)
Balance (in Shares) at Dec. 31, 2020	100,000	65,814	2,875,000				279,723	119,977
Issuance of Class B Ordinary Shares to the Sponsor			$ 288	24,712		25,000
Issuance of Class B Ordinary Shares to the Sponsor (in Shares)			2,875,000
Issuance of Class A Ordinary Shares to the Representative of the underwriters	$ 10			860		870
Issuance of Class A Ordinary Shares to the Representative of the underwriters (in Shares)	100,000
Accretion for public Class A ordinary shares to redemption amount				(2,550,188)		(2,550,188)
Net Profit (Loss) for the period					(97,754)	(97,754)
Balance at Mar. 31, 2021	$ 48		$ 288	855,994	(293,614)	562,716
Balance (in Shares) at Mar. 31, 2021	480,000		2,875,000
Issuance of Class B Ordinary Shares to the Sponsor	$ 38			3,380,610		3,380,648
Issuance of Class B Ordinary Shares to the Sponsor (in Shares)	380,000
Balance at Dec. 31, 2020	$ 10	$ 465,000	$ 288	25,572	(195,860)	(169,990)	$ 10,000,000		[1]	827,000	(10,594,000)	(9,767,000)
Balance (in Shares) at Dec. 31, 2020	100,000	65,814	2,875,000				279,723	119,977
Net Profit (Loss) for the period						(289,547)
Balance at Jun. 30, 2021	$ 48		$ 288	855,994	(485,407)	370,923
Balance (in Shares) at Jun. 30, 2021	480,000		2,875,000
Balance at Dec. 31, 2020	$ 10	$ 465,000	$ 288	25,572	(195,860)	(169,990)	$ 10,000,000		[1]	827,000	(10,594,000)	(9,767,000)
Balance (in Shares) at Dec. 31, 2020	100,000	65,814	2,875,000				279,723	119,977
Sale of 380,000 Private Class A ordinary shares, net of issuance costs (see Note 3)	$ 38			3,380,610		3,380,648
Sale of 380,000 Private Class A ordinary shares, net of issuance costs (see Note 3) (in Shares)	380,000
Accretion for public Class A ordinary shares to redemption amount				(2,550,188)		(2,550,188)
Share based compensation										463,000		463,000
Net Profit (Loss) for the period					(755,218)	(755,218)					(53,484,000)	(53,484,000)
Balance at Dec. 31, 2021	$ 48	$ 465,000	$ 288	855,994	(951,078)	(94,748)	$ 10,000,000		[1]	1,290,000	(64,078,000)	(62,788,000)
Balance (in Shares) at Dec. 31, 2021	480,000	65,814	2,875,000				279,723	119,977
Balance at Mar. 31, 2021	$ 48		$ 288	855,994	(293,614)	562,716
Balance (in Shares) at Mar. 31, 2021	480,000		2,875,000
Net Profit (Loss) for the period					(191,793)	(191,793)
Balance at Jun. 30, 2021	$ 48		$ 288	855,994	(485,407)	370,923
Balance (in Shares) at Jun. 30, 2021	480,000		2,875,000
Balance at Dec. 31, 2021	$ 48	$ 465,000	$ 288	855,994	(951,078)	(94,748)	$ 10,000,000		[1]	1,290,000	(64,078,000)	(62,788,000)
Balance (in Shares) at Dec. 31, 2021	480,000	65,814	2,875,000				279,723	119,977
Net Profit (Loss) for the period					(245,659)	(245,659)
Balance at Mar. 31, 2022	$ 48		$ 288	855,994	(1,196,737)	(340,407)
Balance (in Shares) at Mar. 31, 2022	480,000		2,875,000
Balance at Dec. 31, 2021	$ 48	$ 465,000	$ 288	855,994	(951,078)	(94,748)	$ 10,000,000		[1]	$ 1,290,000	$ (64,078,000)	$ (62,788,000)
Balance (in Shares) at Dec. 31, 2021	480,000	65,814	2,875,000				279,723	119,977
Net Profit (Loss) for the period						(202,966)
Balance at Jun. 30, 2022	$ 48		$ 288	676,895	(1,154,044)	(476,813)
Balance (in Shares) at Jun. 30, 2022	480,000		2,875,000
Balance at Mar. 31, 2022	$ 48		$ 288	855,994	(1,196,737)	(340,407)
Balance (in Shares) at Mar. 31, 2022	480,000		2,875,000
Net Profit (Loss) for the period					42,693	42,693
Balance at Jun. 30, 2022	$ 48		$ 288	676,895	$ (1,154,044)	(476,813)
Balance (in Shares) at Jun. 30, 2022	480,000		2,875,000
Subsequent accretion of Class A Ordinary Shares subject to possible redemption to amount as of June 30, 2022				$ (179,099)		$ (179,099)
[1]Represents an amount less than $1.

Unaudited Condensed Statement_4

Unaudited Condensed Statements of Changes in Shareholders’ Equity (Capital Deficiency) (Parentheticals)	12 Months Ended
	Dec. 31, 2021 shares
Moringa Acquisition Corp
Sale of Private Class A ordinary shares	380,000

Unaudited Condensed Statement_5

Unaudited Condensed Statements of Cash Flows - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss for the period				$ (53,484,000)	$ (3,741,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization				322,000	141,000
Share-based compensation				463,000	413,000
Amortization of debt discount (see Note 7)				808,000
Increase in Funds held by clearing companies				(8,800,000)	(241,000)
Increase in other receivable and prepaid expenses				(2,000,000)	(403,000)
Increase in accounts payable				4,912,000	577,000
Increase in accrued expenses and other liabilities				429,000	118,000
Increase (decrease) in advances from travellers				7,946,000	(6,000)
Increase (decrease) in deferred revenues				1,377,000	(4,000)
Remeasurement of financial assets (see Note 7)				(12,000)
Remeasurement of SAFE				25,207,000
Remeasurement of Warrant liability				17,819,000	97,000
Net cash used in operating activities				(5,013,000)	(3,049,000)
Proceeds from long-term loans				5,500,000
Repayment of long-term loans				(265,000)
Proceeds from issuance of SAFE				1,675,000	325,000
Proceeds from issuance of Preferred A Shares, net					1,092,000
Net cash provided by financing activities				6,910,000	1,417,000
Cash flows from investing activities:
Purchase of property and equipment				(42,000)	(17,000)
Purchase of intangible asse					(896,000)
Investment in short-term deposits				(217,000)	(278,000)
Net cash used in investing activities				(259,000)	(1,191,000)
Cash flows from financing activities:
Increase (decrease) in cash and cash equivalents				1,638,000	(2,823,000)
CASH, CASH EQUIVALENTS AND INVESTMENTS HELD IN A TRUST ACCOUNT AT BEGINNING OF THE PERIOD		$ 2,754,000	$ 1,116,000	1,116,000	3,939,000
CASH, CASH EQUIVALENTS AND INVESTMENTS HELD IN A TRUST ACCOUNT AT END OF THE PERIOD	$ 1,116,000			2,754,000	1,116,000
Supplement disclosure of cash flow information:
Interest paid				416,000
Tax paid				6,000	6,000
Moringa Acquisition Corp
Cash flows from operating activities:
Net loss for the period	(195,860)	(202,966)	(289,547)	(755,218)
Adjustments to reconcile net loss to net cash used in operating activities:
Changes in the fair value of the private warrant liability		(131,537)	4,256	(182,343)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Increase in accounts payable			50,372
Decrease in accrued expenses		(26,411)	(5,896)
Decrease (increase) in prepaid expenses		162,500	(531,353)	(368,853)
Decrease in related party	120,000		(110,000)	(110,000)
Decrease in Accrued expenses and other payables				9,178
Other	860
Net cash used in operating activities	(75,000)	(198,414)	(882,168)	(1,407,236)
Issuance of Class B Ordinary Shares	25,000
Issuance of Class A Ordinary Shares	10
Sale of Public Units			115,000,000	115,000,000
Payment of underwriting commissions and offering expenses			(2,549,158)	(2,549,159)
Sale of Private Units, refer to note 3			3,800,000	3,800,000
Proceeds from a promissory note – related party	149,990	350,000	20,000	320,000
Repayment of promissory note – related party			(169,990)	(169,990)
Payment of deferred offering costs	(48,299)
Net cash provided by financing activities	126,701	350,000	116,100,852	116,400,851
Cash flows from financing activities:
INCREASE IN CASH, CASH EQUIVALENTS AND INVESTMENTS HELD IN A TRUST ACCOUNT	51,701	151,586	115,218,684	114,993,615
CASH, CASH EQUIVALENTS AND INVESTMENTS HELD IN A TRUST ACCOUNT AT BEGINNING OF THE PERIOD		115,045,316	51,701	51,701
CASH, CASH EQUIVALENTS AND INVESTMENTS HELD IN A TRUST ACCOUNT AT END OF THE PERIOD	51,701	115,196,902	115,270,385	115,045,316	51,701
RECONCILIATION OF CASH, CASH EQUIVALENTS AND INVESTMENTS HELD IN A TRUST ACCOUNT:
Cash and cash equivalents	51,701	17,803	267,961	38,944	51,701
Investments held in trust account		115,179,099	115,002,424	115,006,372
Total cash, cash equivalents and investments held in trust account	51,701	115,196,902	115,270,385	115,045,316	51,701
SUPPLEMENTARY INFORMATION REGARDING NON-CASH ACTIVITIES:
Deferred offering costs			$ 77,699	(77,699)
Accrued expenses	$ 29,400				$ 29,400

General

General	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
GENERAL	NOTE 1: a. -based www.gosplitty.com www.traveluro.com b. c. d. e. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern. f. The travel industry has seasonal characteristics, and therefore seasonality has an impact on the activities of the companies operating in this field. In general, it can be said that the summer season is the most active season in the number of bookings in the field of travel. In late 2021 and 2022, the travel market was affected by a pent -up -19 g. -19 In late 2019, the Corona virus (“COVID -19 -19 Following the spread of COVID -19 The decline and even the avoidance of flights caused by the Coronavirus crisis, has caused significant damage to the global travel industry, and as a result, also harmed hotels around the world. The Company first saw the impact of Corona epidemic in the US, the main market in which the Company operates, at the end of the first quarter of 2020 which included a decrease in revenue as a result of a decrease in bookings and an increase in cancellations. As part of Company’s preparation for the crisis following the Corona pandemic, the Company has worked to reduce its fixed and variable expenses including reducing salaries costs and marketing costs. The Company launched its platform in mid -2020 Since the product launch, the Company’s marketing efforts have been primarily in the United States. Even though there have been some improvements in the economic and operating conditions for the Company’s business since the outset of the COVID -19 -term -19

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Significant Accounting Policies [Line Items]
SIGNIFICANT ACCOUNTING POLICIES		NOTE 2: a. The consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) as set forth in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). The consolidated financial statements include accounts of the Company’s wholly -owned b. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, valuation allowance for deferred tax assets, share -based The Company also considered the impact of COVID -19 -lived c. A substantial portion of the Company’s financing activities, including equity transactions and cash investments, are incurred in U.S. dollars. The Company’s managements believes that the U.S. dollar is the currency of the primary economic environment in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar. The Company had determined the functional currency of its foreign subsidiaries is the U.S. dollar. The foreign operations are considered a direct and integral part or extension of the Company’s operations. The day -to-day Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are re -measured d. Cash and cash equivalents are short -term e. -term Short -term -term f. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight -line % Computers and peripheral equipment 33 Office furniture and equipment 7 g. Intangible assets are amortized on a straight -line h. -lived Long -lived i. Revenues are recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), which applies to all contracts with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: • • • • • At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. Company’s revenues are generated by providing online travel reservation services, which allows traveler using the Company’s platform to book hotel room reservation with hotel service providers on a stand -alone The Company’s contracts with hotel service providers provide the Company rates and availability information for rooms without transferring responsibility to deliver the service to the Company. Since the hotel service provider is the primarily responsible for providing the services, and the Company does not control the service provided by the hotel service provider to the traveler, the Company’s revenues are presented on a net basis in the consolidated statements of operations. The Company excludes all taxes assessed by a government authority, if any, from the measurement of transaction prices that are imposed on its travel related services or collected by the Company from travelers (which are therefore excluded from revenue). Cash collected from the travelers in advance includes the amounts owed to the hotel service providers and the Company’s commission. The Company records cash payment received from travelers as advance from travelers and deferred revenue. Advances from travelers represent the principal amount to be payable to the hotel service providers. Deferred revenue represents the Company’s estimated commission from the traveler. Payments to hotel service providers are generally due within 30 days of check -in The Company records the payments in advances from travelers and deferred revenues until the stayed night occurs, at which point the Company recognizes the revenue, net of amounts payable to hotel service providers, as this is when the Company’s performance obligation is satisfied. The balance of deferred revenues reflects the amount of the transaction price of the unsatisfied performance obligations at the end of reporting period. The Company anticipates that it will satisfy all of its performance obligation associated with the deferred revenue within a year of the balance sheet date. According to the Company’s agreement with some of its hotel service providers, the Company is entitled to commission based on the gross volume of revenue generated on the Company’s platform. Variable consideration is included in the transaction price if in the Company’s judgment it is probable that a significant future reversal of cumulative revenue under the contract will not occur. In certain transactions, the traveler has the option to cancel its booking before check -in The travelers pay the Company for the hotel room reservations when they book the reservation by payment to processing companies (“clearing companies”). The funds held by the clearing companies are classified as Funds held by clearing companies. Clearing fees are considered as fulfillment costs. The Company elected to use the practical expedient and recognize the costs as an expense when they occur since the amortization period of the assets that the Company otherwise would have recognized is one year or less. Similarly, the Company does not disclose the value of unsatisfied performance obligations since the original expected duration of the contracts is one year or less. j. Cost of revenue primarily consist of payment processing charges, costs associated with third party data centers used to host the Company’s platform and the amortization of acquired technology (see also Note 5). k. Research and development expenses primarily consist of salaries and benefits related costs, third -party l. Royalty bearing grants from the Israeli Innovation Authority (“IIA”) (previously known as the Office of the Chief Scientist) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a deduction from research and development expenses. The Company recognized participations in research and development as a reduction of research and development expenses for the years ended December 31, 2021 and 2020 in the amount of $321 and $471, respectively. m. Advertising and Marketing costs consisting of online advertising expenses to promote the Company’s brand and expensed (“consumer traffic acquisition cost”) as incurred. For the years ended December 31, 2021 and 2020, advertising and marketing expenses were $12,223 and $1,231, respectively. n. The Company accounts for income taxes in accordance with ASC 740, “Income Taxes.” ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value, if it is more likely than not that some portion of the entire deferred tax asset will not be realized. The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740, “Income Taxes.” Accounting guidance addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements, under which a company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. o. The Company accounts for its contingent liabilities in accordance with ASC No. 450, “Contingencies.” A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2021 and 2020, the Company is not a party to any litigation that could have a material adverse effect on the Company’s business, financial position, results of operations or cash flows. p. Financial instruments that potentially subject the Company to credit risk primarily consist of cash and cash equivalents, short term deposits, funds held by clearing companies and receivables. For cash and cash equivalents, the Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits or similar limits in other jurisdictions. The Company places its cash and cash equivalents and short -term -quality For funds held by clearing companies, the Company is exposed to credit risk in the event of default by the clearing companies. The Company’s clearing companies consists of financial institutions with a high -quality For receivables, the Company is exposed to credit risk in the event of nonpayment to the extent of the amounts recorded on the accompanying consolidated balance sheets. q. The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three -tiered Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at measurement date. Level 2 — Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 — Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Cash and cash equivalents, short -term -term The fair value measurement of warrant liability (Note 7b, 7c and Note 9), SAFE (Note 7a), financial commitment assets (FCA) (Note 7b, 7c) and embedded derivative (Note 7b) are measured using unobservable inputs that require a high level of judgment to determine fair value, and thus are classified as Level 3 financial instruments. The Company estimates the fair value of warrant liability, SAFE, FCA and embedded derivative using the Binominal Option Pricing model, Monta Carlo Simulation model and Probability Weighted Expected Return Method, respectively. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates. r. The Company enters into various monthly operating leases for its operations. In certain lease agreements, the Company may receive renewals or expansion options, rent holidays, and other incentives. Lease expense is recognized over the term of the lease, starting when the Company takes possession of or controls the physical use of the property. s. Pursuant to Section 14 of Israel’s Severance Compensation Law, 1963 (“Section 14”), all of the Company’s employees are included under this section and entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay and the deposits under Section 14 are not recorded as an asset in the Company’s consolidated balance sheets. Severance cost amounted to $193 and $109 for the years ended December 31, 2021 and 2020, respectively. t. The Company computes net loss per share using the two -class -class -rata -converted The Company’s basic net loss per Ordinary Share is calculated by dividing net loss attributable to Ordinary Shares by the weighted -average -if-converted -dilutive u. -based The Company accounts for share -based -Stock -based -pricing The Company recognizes compensation expenses for the value of its awards granted based on the straight -line -line The Company selected the Black -Scholes-Merton -options -pricing v. As an “emerging growth company”, the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflects this election. In August 2020, the FASB issued ASU No. 2020 -06 -06 -06 -40 -06 -06 w. In February 2016, the FASB issued ASU 2016 -02 -of-use -term In June 2016, the FASB issued ASU No. 2016 -13
Moringa Acquisition Corp [Member]
Significant Accounting Policies [Line Items]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES: a. The Company’s unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the SEC for interim financial information and the instructions to Form 10 -Q b. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible, because of the potential differences in accounting standards used. c. The Company considers as cash equivalents all short -term -term As of June 30, 2022, the Company held its cash and cash equivalents in an SVB bank account, and its Investments Held in Trust Account in Goldman Sachs money market funds. Money market funds are characterized as Level I investments within the fair value hierarchy under ASC 820. d. As discussed in Note 1, all of the 11,500,000 -10-S99-3A Immediately upon the Closing of the Public Offering, the Company recognized the accretion from the offering costs allocated to the Class A Ordinary Shares subject to possible redemption, in an amount of $2,551,880. e. The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net profit (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company applies the two -class -Redeemable -Redeemable In order to determine the net loss attributable to each class, the Company first considered the total profit (loss) allocable to both sets of shares. This is calculated using the total net profit (loss) less any Interest Earned on Investments Held in Trust Account. The accretion to redemption value of the Class A ordinary shares subject to possible redemption is fully allocated to the Class A ordinary shares subject to redemption. For each of the three and six months ended June 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into shares and then share in the earnings of the Company. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase an aggregate of 5,940,000 warrants in the calculation of diluted loss per share, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net profit (loss) per share is the same as basic net profit (loss) per share for each of the periods presented, and for each class. f. Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. g. The Company applied the provisions of ASC 815 -40 h. The Company accounts for the warrants in accordance with the guidance contained in Accounting Standards Codification 815 (“ASC 815”), “Derivatives and Hedging,” under which the warrants do not meet the criteria for equity treatment and must be recorded as derivative liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re -measurement -Scholes-Merton i. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short -term j. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on the Company’s financial statements. k. The Company accounts for income taxes in accordance with ASC 740, “Income Taxes (hereafter — ASC 740). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non -current The Company accounts for uncertain tax positions in accordance with ASC 740 -10 -10 -step l. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted would have a material effect on the Company’s financial statements.	NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES: a. The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the SEC. b. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible, because of the potential differences in accounting standards used. c. The Company considers as cash equivalents all short -term -term As of December 31, 2021, the Company held its cash and cash equivalents in an SVB bank account, and its investments Held in Trust Account in Goldman Sachs money market funds. Money market funds are characterized as Level I investments within the fair value hierarchy under ASC 820. d. As discussed in Note 1, all of the 11,500,000 -10-S99-3A Immediately upon the Closing of the Public Offering, the Company recognized the accretion from the offering costs allocated to the Class A Ordinary Shares subject to possible redemption. As of December 31, 2021, the shares of Class A Ordinary Shares subject to possible redemption reflected on the balance sheet are reconciled in the following table: As of December 31, 2021 Gross proceeds $ 115,000,000 Less: Portion of offering costs attributable to Class A shares subject to possible redemption $ (2,551,880 ) Plus: Accretion to redemption value $ 2,551,880 Class A ordinary shares subject to possible redemption $ 115,000,000 e. The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company applies the two -class -redeemable As of December 31, 2021, the Company had outstanding warrants to purchase up to 5,940,000 f. Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. g. The Company applied the provisions of ASC 815 -40 g. The Company accounts for the warrants in accordance with the guidance contained in Accounting Standards Codification 815 (“ASC 815”), “Derivatives and Hedging,” under which the warrants do not meet the criteria for equity treatment and must be recorded as derivative liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re -measurement -Scholes-Merton h. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short -term i. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on the Company’s financial statements. j. The Company complies with the requirements of the Accounting Standards Codification 340 -10-S99-1 Out of the total amount of offering costs, an amount of $7,599 was allocated to the Private Warrant Liability, and therefore charged as an expense. k. The Company accounts for income taxes in accordance with ASC 740, “Income Taxes (hereafter — ASC 740). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non -current The Company accounts for uncertain tax positions in accordance with ASC 740 -10 -10 -step

Other Receivables and Prepaid E

Other Receivables and Prepaid Expenses	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
OTHER RECEIVABLES AND PREPAID EXPENSES	NOTE 3: December 31, 2021 2020 Deposits* ) $ 588 $ 281 AII grants receivable 120 83 Prepaid expenses 1,188 119 Governmental institutions 116 25 Income to receive from hotel service providers 496 — Other 7 7 $ 2,515 $ 515 __________ *)

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	NOTE 4: Composition of property and equipment is as follows: December 31, 2021 2020 Cost: Computers and peripheral equipment $ 103 $ 62 Office furniture and equipment 3 2 106 64 Accumulated depreciation: Computers and peripheral equipment 56 35 Office furniture and equipment 2 — 58 35 Depreciated cost $ 48 $ 29 Depreciation expenses for the years ended December 31, 2021 and 2020 were $23 and $17, respectively.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 5: In July 2020, the Company completed the acquisition of technology from an Israeli company in the travel industry, for a total consideration of approximately $896 (net of acquisition cost). The purchase price of the technology is amortized over 3 years. Amortization expense for the years ended December 31, 2021 and 2020 amounted to $299 and $124, respectively, and is included in cost of revenues.

Other Accounts Payable and Accr

Other Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2021
Other Accounts Payable and Accrued Expenses [Abstract]
OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES	NOTE 6: December 31, 2021 2020 Paycheck protection program loan (1) $ — $ 21 Employees liabilities 468 253 Accrued expenses 273 37 Government institutions 4 5 $ 745 $ 316 (1)

Long-Term Loans

Long-Term Loans	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
LONG-TERM LOANS	NOTE 7: a. Pursuant to the applicable agreements, the SAFE automatically converts into Preferred Shares upon a future equity financing of at least $3,000 in which the Company sold such Preferred Shares. The number of Preferred Shares into which the SAFE would convert would be SAFE amount divided by the lower of (i) per -share -share Company Capitalization Safe Price -share -share Upon an event of liquidation (e.g., change in control or initial public offering (which includes a merger transaction with a SPAC) or dissolution), SAFE holders can choose to either receive cash payment equal to their respective SAFE investment amount or receive from the Company a number of Ordinary Shares equal to the SAFE investment amount divided by a per -share Upon an event of dissolution, SAFE holders can choose to either receive cash payment equal to their respective SAFE investment amount or receive from the Company a number of the most senior class of Company shares existing at such time, obtained by dividing their respective SAFE investment amount by price per -share -passu -rata SAFE holders, by virtue of the SAFE, do not have dividend or voting rights prior to the conversion of the SAFE into shares of the Company. The SAFE are liabilities pursuant to ASC 480 -10-25-8 Under a change in control scenario, the Company will be required to transfer assets. Therefore, the SAFE are required to be initially and subsequently measured at fair value with changes in fair value recognized in earnings pursuant to ASC 480 -10-30-7 -10-35-5 The fair value of the SAFE as December 31, 2021 is $27,207. See also Note 14. b. Loan Agreement As part of the terms of the loan, if the Company meets the terms as specified in the Loan Agreement, the Company will be entitled to an increase in the loan by $1,000 (the “ Additional Loan In addition, as part of the terms of the Loan Agreement, the Company granted to Discount Capital, a Warrant to purchase 20,591 Preferred A Shares at an exercise price of $36.909. The Warrant can be exercised for 7 years from its grant or at the consummation of a qualified acquisition as specified in the Warrant, whichever is earlier. The Company has determined that the Loan Agreement contained three, legally detachable and separately exercisable, freestanding financial instruments: The term loan, the Financial Commitment Asset (“FCA”) (the right to receive additional financing) and the Warrant. Pursuant to the Loan Agreement, in the event that the Company raises more than $10,000 in an equity financing, the monthly repayment amount of the principal for 6 months will be reduced to 2% instead of 3%. The deferred principal payments will be paid at maturity. The Company has concluded that the deferral of the principal payments’ feature is not considered clearly and closely related to debt host instrument and meet the definition of a derivative pursuant to ASC 815. Consequently, the Company bifurcated the embedded derivative component (“Reduced Principal payment derivative”) from the debt host instrument, measured at fair value through earnings with changes in fair value classified as financial expenses (income). For presentation purposes, the embedded derivative is presented as part of the loan in the consolidated balance sheets (See Note 14). The Warrant was classified as a liability pursuant to ASC 480 as the underlying shares are contingently redeemable in an event that is not under the Company’s control and was measured at fair value through earnings (See Note 14). The FCA was classified as an asset since the underlying of the FCA is a debt instrument and therefore, the FCA is not considered indexed to the Company’s own equity pursuant to ASC 815 -40 The initial $3,000 of proceeds received pursuant to the Loan Agreement were allocated to the Warrant, to the FCA and to the embedded derivative at fair value with the residual proceeds in the amount of $2,733 were allocated to the term loan, creating a debt discount which will be amortized using the effective interest method. c. Second Loan Agreement As part of the terms of the loan, if the Company meets the terms as specified in the Second Loan Agreement, the Company will be entitled to an increase in the loan by another $1,500 (the “ New Additional Loan In addition, as part of the terms of the Second Loan Agreement, the Company granted an additional Warrant to Discount Capital, according to which Discount Capital is entitled to purchase 2,400 Preference A Shares of the Company at the par value of NIS 0.01 per share, and can be exercised for 7 years from its grant or at the consummation of a qualified acquisition as specified in such additional Warrant, whichever is earlier. If the Company does not consummate an equity capital raise reflecting a Company pre money valuation of at least $100,000 during the first 6 months following the agreement date, then, the Company shall grant Discount Capital an additional Warrant to purchase additional 1,200 Preferred A Shares at the par value of NIS 0.01 per share. At the earlier of (i) the lapse of 6 months from the loan withdrawal, and (ii) consummation of the merger transaction then being negotiated, the Company shall pay Discount Capital a one -time The Company has determined that the Second Loan Agreement contained three, legally detachable and separately exercisable, freestanding financial instruments: The term loan, the Financial Commitment Asset (“FCA”) (the right to receive additional financing) and the Warrant. The Warrant was classified as a liability pursuant to ASC 480 as the underlying shares are contingently redeemable in an event that is not under the Company’s control and was measured at fair value through earnings (See Note 14). The FCA was classified as an asset since the underlying of the FCA is a debt instrument and therefore, the FCA is not considered indexed to the Company’s own equity pursuant to ASC 815 -40 The initial $1,500 of proceeds received pursuant to the amendment to the Financing Agreement were allocated to the Warrant and to the FCA at fair value with the residual proceeds in the amount of $895 were allocated to the term loan, creating a debt discount which will be amortized using the effective interest method. d. PPP SBA CARES Act PPP Loan the average monthly payroll expenses of the qualifying business. The loan and accrued interest are forgivable after eight weeks if the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities. The amount of loan forgiveness may be reduced if the borrower terminates employees or reduces salaries during the eight -week The Company used the proceeds for purposes consistent with the PPP. On April 16, 2021, Splitty Inc. received confirmation from the SBA that the PPP loan had been forgiven in full including all interest accrued. Accordingly, the Company recognized $109 of financial income for the debt extinguishment pursuant to ASC 470 -50-15-4 e. The 2021 SAFE would automatically convert into Ordinary Shares upon a merger transaction or a future equity financing. The number of shares into which the 2021 SAFE would convert would be 2021 SAFE amount divided by the per -share If the 2021 SAFE has not terminated or expired upon the lapse of 12 months from such time when a 2021 SAFE holder has actually invested in the Company, then, at any time thereafter, if there is an equity financing, the 2021 SAFE will convert to shares of the Company, of the same type as issued to the investors in the equity financing, by dividing the 2021 SAFE investment by a per -share -share -share The number of shares that could be issued upon conversion of the 2021 SAFE was not limited. If the 2021 SAFE has not terminated or expired upon the lapse of 12 months from such time when a 2021 SAFE holder has actually invested in the Company, then upon an event of liquidation (e.g., change in control or initial public offering), 2021 SAFE holders can choose to either receive cash payment equal to two times their respective 2021 SAFE investment amount, or receive from the Company a number of Ordinary Shares equal to the 2021 SAFE investment amount divided by a per -share -share Upon dissolution, each of the 2021 SAFE holders would be entitled to receive cash payment equal to such investor’s 2021 SAFE investment amount. Such right will be senior to the rights of Company’s shareholders to receive distribution, and shall be pari -passu -rata 2021 SAFE holders by virtue of the 2021 SAFE, do not have dividend or voting rights as long as the 2021 SAFE hasn’t been converted into shares of the Company. See also Note 16 for subsequent event.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Commitments and Contingent Liabilities [Line Items]
COMMITMENTS AND CONTINGENT LIABILITIES	NOTE 8: a. Aggregate minimum monthly rental commitments for continuing operations under the Company’s leases are immaterial. Expenses for lease of facilities for the years ended December 31, 2021 and 2020 were $118 and $88, respectively. Expense for the lease of motor vehicles for the years ended December 31, 2021 and 2020 were $28 and $25, respectively. b. -linked -month c. Pursuant to the Loan Agreement and Second loan agreement with Discount Capital (Note 7b and 7c), the Company has committed to the following financial covenants towards: • • In the event that in light of the financial condition of the Company or the market terms the Company shall reduce the aggregate amount of all of its deposits as determined in Loan Agreement (whether existing or future), the Minimum Cash Amount shall be further increased as set in the Loan Agreement. • • • As of December 31, 2021 the Company is in compliance with these covenants. In addition, the Company granted a first -ranking d. e. On August 20, 2021, an unaffiliated third party filed suit against Splitty Inc., the Company and its hotel service provider, seeking an amount between $50 to $75, including claims of unfair trade practices and tortious interference with contract. In October 2021, the Company received a notice of voluntary dismissal without prejudice. The Company is not currently a party, as plaintiff or defendant, to any legal proceedings that, individually or in the aggregate, are expected by the Company to have a material effect on its financial statements. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, then the estimated loss is accrued by the Company to the consolidated statement of operation. These accruals are reviewed at least yearly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a matter.
Moringa Acquisition Corp [Member]
Commitments and Contingent Liabilities [Line Items]
COMMITMENTS AND CONTINGENT LIABILITIES	NOTE 5 — COMMITMENTS AND CONTINGENCIES: Underwriters’ Deferred Commission Under the Business Combination Marketing Agreement, the Company shall pay an additional fee (hereafter — the Deferred Commission) of 3.5% of the gross proceeds of the Public Offering (or $4,025,000) payable upon the Company’s completion of the initial Business Combination. The Deferred Commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes the Initial Business Combination.	NOTE 5 — COMMITMENTS AND CONTINGENCIES: Underwriters’ Deferred Discount Under the Business Combination Marketing Agreement, the Company shall pay an additional fee (hereafter — the Deferred Discount) of 3.5% of the gross proceeds of the Public Offering (or $4,025,000) payable upon the Company’s completion of the initial Business Combination. The Deferred Discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes the Initial Business Combination.

Preferred Shares and Ordinary A

Preferred Shares and Ordinary A Shares	12 Months Ended
	Dec. 31, 2021
Preferred Shares And Ordinary AShares Abstract
PREFERRED SHARES AND ORDINARY A SHARES	NOTE 9: Composition of Preferred Shares and Ordinary A Shares: December 31, December 31, Authorized Issued and outstanding Authorized Issued and outstanding Ordinary A Shares 74,220 65,814 74,220 65,814 Preferred A Shares 242,000 201,712 226,000 201,712 Preferred A1- Shares 14,000 13,423 14,000 13,423 Preferred A2- Shares 64,978 64,588 64,978 64,588 395,198 345,537 379,198 345,537 The Preferred Shares and Ordinary A Shares have various rights, privileges and preferences as follows: Liquidation Preference: Holders of Preferred Shares have liquidation preference over the holders of Ordinary A Shares and Ordinary Shares, such that each holder of Preferred Shares is entitled to receive, upon liquidation event (e.g., change in control), the higher of (i) the price per share paid by it per each Preferred Share plus interest thereon at a rate per annum equal to 12% compounded annually plus all declared but unpaid dividends thereon, less any amount paid (or value of asset distributed) as dividends in respect of such share in preference over the Ordinary A Shares and Ordinary Shares, and (ii) its pro -rata -rata -passu -converted Holders of Ordinary A Shares have liquidation preference over the holders of Ordinary Shares but are junior to the preference of the Preferred Shares, such that each holder of Ordinary A Shares is entitled to receive, upon liquidation event, the higher of (i) the price per share paid by it per each Ordinary A Shares plus all declared but unpaid dividends thereon, less any amount paid (or value of asset distributed) as dividends in respect of such share in preference over the Ordinary Shares, and (ii) its pro -rata -rata -passu -converted Following the full payment of the entire preferred preference to the holders of Preferred Shares and Ordinary A Shares, the holders of the Ordinary Shares will be entitled to receive the remaining distribution proceeds (if any), pro rata based on the number of Ordinary Shares held by each such holder. Dividend: The Preferred Share and Ordinary A Shares are entitled to dividend only when and if declared by the Company’s Board of Directors. Each holder of Preferred Shares shall be entitled to receive, on a pari -passu -cumulative After payment in full of all amounts payable and distributable to the holders of the Preferred Shares, each holder of Ordinary A Shares shall be entitled to receive, on a pari -passu -cumulative Conversion: Each Preferred Share and Ordinary A Share is convertible, at the option of the holder at any time, into the number of the Company’s Ordinary Shares as is determined by dividing the original issuance price for such series of Preferred Shares and Ordinary A Shares by the conversion price for such series of Preferred Share and Ordinary A Shares that is in effect at the time of conversion. The initial price for the series of Preferred Shares and Ordinary A Shares is the original issue price for such series of Preferred Shares and Ordinary A Shares. The applicable conversion price of each series of Preferred Shares or Ordinary A Shares is subject to adjustment upon stock splits or combination and recapitalizations. Each series Preferred Shares and Ordinary A Shares shall respectively automatically be converted into Ordinary Share upon the earlier of: (i) the date, or the occurrence of an event, specified by vote or written consent of the holders of more than fifty percent (50%) of the then issued and outstanding, at the then effective conversion price, upon the closing of the sale of the Company’s Ordinary Shares to the public in a firm commitment underwritten public offering, at a pre -money Voting: Each of the series of Preferred Shares and Ordinary A Shares are entitled to one vote for each Company’s Ordinary Shares into which such series of Preferred Shares and Ordinary A Shares could be converted. Redemption: The Preferred Share and Ordinary A Shares are redeemable upon the occurrence of a liquidation event. The Preferred Shares and Ordinary A Shares are not redeemable on a fixed date or upon a contingent event that is certain to occur. a. In liquidation event (e.g., change in control) the liquidation preference provisions of the Preferred Shares and Ordinary A Shares are considered contingent redemption provisions that are not solely within the Company’s control. Accordingly, the Preferred Shares and Ordinary A Shares have been presented outside of permanent equity in the temporary equity (mezzanine) section of the consolidated financial statements. As of December 31, 2021 and 2020, the Company did not adjust the carrying values of the Preferred Shares and Ordinary A Shares to the deemed liquidation values of such shares since a liquidation event was not probable. Subsequent adjustments to increase the carrying values to the ultimate liquidation values will be made only when it becomes probable that such a deemed liquidation event will occur. b. The Investors Warrants are exercisable to 14,838 Preferred A Shares of NIS 0.01 par value with an exercise price of $36.9. The Investors Warrants can be exercised for 48 months from the date of the closing. These warrants were classified as liabilities, initially and subsequently measured at fair value through earnings pursuant to ASC 480 as the underlying shares are contingently redeemable in an event not under the Company’s control.

Shareholders' Equity

Shareholders' Equity	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Shareholders' Equity [Line Items]
SHAREHOLDERS' EQUITY		NOTE 10: SHAREHOLDERS’ EQUITY Ordinary Shares of the Company confer on their holders’ voting rights, rights to receive dividends, rights to receive a distribution of assets upon liquidation and certain other rights as described in the Company’s amended and restated articles and under the Israeli Companies Law, 5759 -1999 December 31, December 31, Authorized Issued and outstanding Authorized Issued and outstanding Ordinary Shares 604,780 119,977 620,780 119,977 During 2021, the Company’s board of directors and shareholders approved the reclassification of 16,000 authorized Ordinary Shares to 16,000 authorized Preferred A Shares.
Moringa Acquisition Corp [Member]
Shareholders' Equity [Line Items]
SHAREHOLDERS' EQUITY	NOTE 7 — CAPITAL DEFICIENCY: a. Class A Ordinary Shares On November 20, 2020 the Company issued 100,000 Class A ordinary shares of $0.0001 par value each to designees of the Representative (hereafter — the Representative Shares) for a consideration equal to the par value of the shares. The Representative Shares are deemed to be underwriters’ compensation by FINRA pursuant to Rule 5110 of the FINRA Manual. The Company accounted for the issuance of the Representative Shares as compensation expenses amounting to $860, with a corresponding credit to Additional Paid -In Pursuant to the initial Public Offering and the concurrent Private Placement that were each effected in two closings — on February 19, 2021 and March 3, 2021 — the Company issued and sold an aggregate of 11,500,000 and 380,000 Class A ordinary shares as part of the Units sold in those respective transactions. The Units (which also included Warrants) were sold at a price of $10 per Unit, and for an aggregate consideration of $115 million and $3.8 million in the Public Offering and Private Placement, respectively. See Note 3 above for further information regarding those share issuances. The Company classified its 11,500,000 Public Class A ordinary shares as temporary equity. The remaining 480,000 Private Class A ordinary shares were classified as permanent equity. Class B Ordinary Shares On November 20, 2020 the Company issued 2,875,000 Class B ordinary shares of $0.0001 par value each for a total consideration of $25 thousand to the Sponsor’s wholly -owned -allotment -allotment Class B ordinary shares are convertible into non -redeemable -for-one . b. The Company is authorized to issue up to 5,000,000 Preferred Shares of $0.0001 par value each. As of June 30, 2022, the Company has no preferred shares issued and outstanding.	NOTE 7 — CAPITAL DEFICIENCY: a. Class A Ordinary Shares On November 20, 2020 the Company issued 100,000 Class A ordinary shares of $0.0001 par value each to designees of the Representative (hereafter — the Representative Shares) for a consideration equal to the par value of the shares. The Representative Shares are deemed to be underwriters’ compensation by FINRA pursuant to Rule 5110 of the FINRA Manual. The Company accounted for the issuance of the Representative Shares as compensation expenses amounting to $860, with a corresponding credit to Additional Paid -In Pursuant to the initial Public Offering and the concurrent Private Placement that were each effected in two closings — on February 19, 2021 and March 3, 2021 — the Company issued and sold an aggregate of 11,500,000 and 380,000 Class A ordinary shares as part of the Units sold in those respective transactions. The Units (which also included Warrants) were sold at a price of $10 per Unit, and for an aggregate consideration of $115 million and $3.8 million in the Public Offering and Private Placement, respectively. See Note 3 above for further information regarding those share issuances. The Company classified its 11,500,000 Public Class A ordinary shares as temporary equity. The remaining 480,000 Private Class A ordinary shares were classified as permanent equity. Class B Ordinary Shares On November 20, 2020 the Company issued 2,875,000 Class B ordinary shares of $0.0001 par value each for a total consideration of $25 thousand to the Sponsor’s wholly -owned -allotment -allotment Class B ordinary shares are convertible into non -redeemable -for-one b. The Company is authorized to issue up to 5,000,000 Preferred Shares of $0.0001 par value each. As of December 31, 2021, the Company has no preferred shares issued and outstanding.

Share Based Compensation

Share Based Compensation	12 Months Ended
	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
SHARE BASED COMPENSATION	NOTE 11: SHARE BASED COMPENSATION a. b. A summary of the Company’s share option plan activity is as follows: Number of options Weighted average exercise price Weighted average Remaining Contractual Life (Years) Aggregated Intrinsic Value (thousand) Outstanding as of January 1, 2020 25,724 $ 13.17 7.52 $ 76 Granted 7,401 $ 16.38 Exercised — $ — Forfeited (592 ) $ 17.35 Outstanding as of December 31, 2020 32,533 $ 13.82 7.8 $ 79 Granted 8,359 $ 17.35 Exercised — — Forfeited — — Outstanding as of December 31, 2021 40,892 $ 14.55 8.11 $ 372 Exercisable as of December 31, 2020 16,866 $ 11.73 7.75 $ 69 Exercisable as of December 31, 2021 26,517 $ 14.82 7.9 $ 163 The fair value of share options granted during the years ended December 31, 2020 and 2021 were estimated at the date of grant using the Black -Scholes -pricing 2021 2020 Average Exercise price (Doller) 17.35 17.35 Expected volatility (%) 55.57% – 73.11% 80% Risk-free interest rate (%) 0.76% – 1.15% 0.49% – 0.69% Expected term (Years) 6.25 6 Expected dividend yield (%) — — In determining the exercise prices for share options granted, the board of directors considered the fair value of the Company Ordinary Share as of each grant date. The fair value of the Company Ordinary Share underlying the share options was determined by management and approved by the Company’s board of directors. Management has determined fair value of an Ordinary Share at the time of grant of the option by considering a number of objective and subjective factors including financing investment rounds, operating and financial performance, the lack of liquidity of share capital, the effect of the rights and preferences of the Company Preferred shareholders and general and industry specific economic outlook, amongst other factors. The Company’s management determined the fair value of Ordinary Share based on valuations performed using the Option Pricing Method (“OPM”) and the Probability Weighted Expected Return Method (“PWERM”) subject to relevant facts and circumstances. Expected volatility As the Company is privately owned, there is not sufficient historical volatility for the expected term of the share options. Therefore, the Company uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly traded companies which were selected based upon industry similarities. Expected term (years): Expected term represents the period that the Company’s option grants are expected to be outstanding. There is not sufficient historical share exercise data to calculate the expected term of the share options. Therefore, the Company elected to utilize the simplified method to value option grants. Under this approach, the weighted -average Risk-free interest rate The Company determined the risk -free -average Expected dividend yield The Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield. As of December 31, 2021 and 2020, unrecognized compensation costs related to share options was $891 and $349, respectively, which was expected to be recognized over a weighted average period of 3 years and 3 years, respectively. The weighted average grant date fair value of options granted during the years ended December 31, 2021 and 2020 was $21.37 and $13.41, respectively. The share -based December 31, 2021 2020 Research and development, net $ 198 $ 168 Sales and marketing 73 59 General and administrative 192 186 $ 463 $ 413

Taxes on Income

Taxes on Income	12 Months Ended
	Dec. 31, 2021
Schedule of reconciliation of the tax benefit at the israeli statutory tax rate [Abstract]
Taxes on Income	NOTE 12: TAXES ON INCOME a. The corporate tax rate in Israel in 2018 thereafter is 23%. b. The Company’s US subsidiary is subject to U.S. federal tax at the rate of 21%. c. The Company and its subsidiaries have not received final tax assessments since its incorporation. d. December 31 2021 2020 Domestic (Israel) $ (53,499 ) $ (3,759 ) Foreign 21 23 $ (53,478 ) $ (3,736 ) e. December 31 2021 2020 Current Domestic — — Foreign $ 6 $ 5 $ 6 $ 5 f. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The approximate amount of the Company’s deferred tax assets and liabilities are as follow: December 31, 2021 2020 Deferred tax asset Vacation accrual $ 24 $ 25 R&D deferred expenses 150 370 Intangible assets 63 18 Operating loss carryforward 3,633 1,693 Valuation allowance (3,840 ) (2,106 ) Total deferred tax asset net 30 — Deferred tax liability Long term loan (30 ) — Total deferred tax liability (30 ) — $ — $ — In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon the level of historical taxable loss and projections for future taxable losses over the period in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will not realize the benefits of these deductible differences as of December 31, 2021 and 2020 and accordingly, a full valuation allowance has been maintained and no deferred tax assets were shown in the accompanying balance sheet. As of December 31, 2021, the Company has net operating loss carryforwards for Israeli income tax purposes of $7,608, which may be offset indefinitely against future taxable income. g. December 31, 2021 2020 Israel tax provision at statutory rate 23.0 % 23.0 % Non-deductible fair value valuations expenses (18.8 )% (0.6 )% Non-deductible stock compensation (0.2 )% (2.5 )% Change in valuation allowance (3.99 )% (19.8 )% Effective tax rate 0.01 % 0.1 % h. The Company has reviewed the tax positions taken, or to be taken, in the Company’s tax returns for all tax years currently open to examination by a taxing authority. As of December 31, 2021 and 2020, the Company has not recorded any uncertain tax position liability.

Reporting Segments and Geograph

Reporting Segments and Geographic Information	12 Months Ended
	Dec. 31, 2021
Reporting Segments and Geographic Information [Abstract]
REPORTING SEGMENTS AND GEOGRAPHIC INFORMATION	NOTE 13: REPORTING SEGMENTS AND GEOGRAPHIC INFORMATION Operating segments: The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, which is the Company’s chief executive officer, in deciding how to make operating decisions, allocate resources and assess performance. The Company’s chief operating decision maker allocates resources and assesses performance at the consolidated level. Geographical information: Revenue disaggregated by geography, based on the billing address of the Company’s traveler, consists of the following: December 31, 2021 2020 North America $ 14,160 $ 1,168 Other 908 36 $ 15,068 $ 1,204 The geographical area of all long -lived

Fair Value Measurements

Fair Value Measurements	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value Measurements [Line Items]
FAIR VALUE MEASUREMENTS		NOTE 14: FAIR VALUE MEASUREMENTS The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis: December 31, Level 2020 2021 Financial liabilities: SAFE 3 $ 27,207 $ 325 Warrant liability 3 19,346 383 Financial assets: FCA 3 (203 ) — Reduced principal payment derivative 3 (16 ) — $ 46,334 $ 708 The fair value measurement of the SAFE, warrant liability, FCA and reduced principal payment derivative are measured using unobservable inputs that require a high level of judgement to determine their fair value, and thus are classified as Level 3 financial instruments. The Company estimates the fair value of SAFE and warrant liability using the Monte Carlo simulation model, the Black -Scholes -pricing The Company estimates the fair value of the FCA and reduced principal payment derivative using the Probability Weighted Expected Return Method The key inputs used in the valuation of the SAFE (see also Note 7a) as of December 31, 2021 and at the initial measurement date: Input December 31, 2021 January 2021 Initial measurement Expected fair value per share of Preferred Shares $ 68.10 $ 54.94 Expected fair value per share of Ordinary Shares $ 38.53 $ 41.43 Probability of equity financing occurrence 5 % 50 % Probability of liquidity event occurrence 95 % 50 % Probability of dissolution occurrence 0 % 0 % Discount upon conversion to Preferred Share 10 % 10 % Time to liquidity (years) 0.5 1 Risk-Free Interest 0.19 % 0.1 % Underlying asset volatility 62.67 102.9 % The key inputs used in the valuation of the investor warrant liability (see also Note 9b) as of December 31, 2021 and 2020 and at the initial measurement date: Input December 31, 2021 December 31, 2020 September 30, Initial measurement Exercise price $ 36.91 $ 36.91 $ 36.91 Time to liquidation (years) 0.5 1 1.25 Risk free rate 0.19 % 0.1 % 0.01 % Expected Volatility 62.67 % 102.9 % 118.4 % Probability of initial public offering occurrence 95 % 50 % 50 % Probability of equity financing occurrence 5 % 50 % 50 % The key inputs used in the valuation of the Discount warrant liability (see also Note 7b and Note 7c) as of December 31, 2021, and at the initial measurement date: Input December 31, 2021 October 13, Initial Measurement March 25, Initial Measurement Exercise price $ 0.01 – $36.909 $ 0.01 $ 36.909 Time to liquidation (years) 0.5 0.22 0.75 Risk free rate 0.19% 0.05 % 0.06 % Expected Volatility 62.67% 59.65 % 93.96 % Probability of initial public offering occurrence 95% 60 % 50 % Probability of equity financing occurrence 5% 40 % 50 % Reduced Principal payment derivative: As stated in Note 7b, in the event that the Company raises more than $10,000 in an equity financing, the monthly repayment amount of the loan principal amount for 6 months will be reduced to 2% instead of 3%. The fair value of the reduced principal payment derivative fair value was calculated as the difference between the fair value of the primary loan with the expected principal payments decrease, and the fair value of the primary loan without the expected principal payments decrease. Financial commitment asset: As stated in Note 7b, the Loan Agreement includes the right to receive additional financing, FCA, which the Company measured at fair value, and classified as Level 3 financial instrument. As of March 25, 2021 (the initial measurement date) the FCA fair value amounted to $122, and at the expiration date on July 13, 2021 the FCA fair value was $65. As stated in Note 7c, the Loan Agreement includes the right to receive additional financing, FCA, which the Company measured at fair value, and classified as Level 3 financial instrument. As of October 13, 2021 (the initial measurement date) the FCA fair value amounted to $134. The following table presents the summary of the changes in the fair value of our Level 3 financial instruments: SAFE Balance as of January 1, 2020 $ — Issuance of SAFE 325 Balance as of December 31, 2020 325 Issuance of SAFE 1,675 Change in fair value 25,207 Balance as of December 31, 2021 $ 27,207 Warrant Balance as of January 1, 2020 $ — Issuance of investors warrants 286 Change in fair value 97 Balance as of December 31, 2020 383 Issuance of Discount warrants 1,144 Change in fair value 17,819 Balance as of December 31, 2021 $ 19,346 Reduced Balance as of December 31, 2020 $ — $ — Issuance of FCA 256 16 Change in fair value (12 ) (* Exercise of FCA (65 ) — Balance as of December 31, 2021 $ 203 $ 16 __________ *)
Moringa Acquisition Corp [Member]
Fair Value Measurements [Line Items]
FAIR VALUE MEASUREMENTS	NOTE 6 — FAIR VALUE MEASUREMENTS: The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). The fair value hierarchy under ASC 820 prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Basis for Fair Value Measurement Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active or financial instruments for which significant inputs to models are observable (including but not limited to quoted prices for similar securities, interest rates, foreign exchange rates, volatility and credit risk), either directly or indirectly; Level 3: Prices or valuations that require significant unobservable inputs (including the Management’s assumptions in determining fair value measurement). The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2022 by level within the fair value hierarchy: Level June 30, December 31, 2021 Assets: Money market funds held in Trust Account 1 115,179,099 115,006,372 Liabilities: Private Warrant Liability 3 28,804 160,341 The estimated fair value of the Private Placement Warrants was determined using a binomial model to extract the market’s implied probability for an Initial Business Combination, using the Public Warrant’s market price. Once probability was extracted, a Black -Scholes-Merton -Scholes-Merton -free -free -coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs: June 30, December 31, Share price $ 10.0 10.0 Strike price $ 11.5 11.5 Volatility 50 % 50 % Risk-free interest rate 3.00 % 1.26 % Dividend yield 0.00 % 0.00 %	NOTE 6 — FAIR VALUE MEASUREMENTS: The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). The fair value hierarchy under ASC 820 prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Basis for Fair Value Measurement Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active or financial instruments for which significant inputs to models are observable (including but not limited to quoted prices for similar securities, interest rates, foreign exchange rates, volatility and credit risk), either directly or indirectly; Level 3: Prices or valuations that require significant unobservable inputs (including the Management’s assumptions in determining fair value measurement). The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021 by level within the fair value hierarchy: Level December 31, 2021 Assets: Money market funds held in Trust Account 1 115,006,372 Liabilities: Private Warrant Liability 3 160,341 The estimated fair value of the Private Placement Warrants was determined using a binomial model to extract the market’s implied probability for an Initial Business Combination, using the Public Warrant’s market price. Once probability was extracted, a Black -Scholes-Merton -Scholes-Merton -free -free -coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs: As of Share price $ 10.0 Strike price $ 11.5 Term (in years) 5.5 Volatility 50 % Risk-free interest rate 1.26 % Dividend yield 0.00 % The change in the fair value of the Warrants measured with Level 3 inputs for the period from March 3, 2021 (Initial Measurement) through December 31, 2021 is summarized as follows: In U.S. dollars Value of private warrant liability measured with Level 3 inputs at Initial Measurement 342,684 Change in fair value of private warrant liability measured with Level 3 inputs (182,343 ) Transfer in/out — Value of warrant liability measured with Level 3 inputs at December 31, 2021 160,341

Loss per Share

Loss per Share	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Loss per Share [Line Items]
LOSS PER SHARE		NOTE 15: LOSS PER SHARE The following table sets forth the computation of basic and diluted loss per share attributed to the Ordinary shareholders for the periods presented: Year ended 2021 2020 Numerator: Net loss attributable to the Company Ordinary Shares $ 53,484 $ 3,741 Denominator: Weighted average stock used in computing net loss per share attributed to Ordinary Shares, basic and diluted 87,487 65,639 Net loss per share attributable to Ordinary Shares, basic and diluted: $ (611.33 ) $ (56.99 ) The potential Ordinary Shares that were excluded from the computation of diluted net loss per shares attributable to Ordinary shareholders for the periods presented because including them would have been anti -dilutive Year ended 2021 2020 Restricted Ordinary Shares 23,116 41,608 Preferred Shares 279,723 279,723 Ordinary A Share 65,814 65,814 Warrant liability 37,374 14,383 SAFE 51,989 8,448 Outstanding share options 40,892 32,533 Total 498,908 442,509
Moringa Acquisition Corp [Member]
Loss per Share [Line Items]
LOSS PER SHARE	NOTE 8 — NET PROFIT (LOSS) PER SHARE: The following table reflects the calculation of basic and diluted net profit (loss) per share (in dollars, except share amounts): Six months ended Three months ended 2022 2021 2022 2021 Net profit (loss) $ (202,966 ) $ (289,547 ) $ 42,693 $ (191,793 ) Accretion to Class A ordinary shares subject to possible redemption to redemption amount (“Accretion”) (172,727 ) — (163,341 ) — Net loss including Accretion $ (375,693 ) $ (289,547 ) $ (120,648 ) $ (191,793 ) Class A ordinary shares subject to possible redemption: Numerator: Net loss including Accretion $ (290,843 ) $ (207,447 ) $ (93,400 ) $ (148,477 ) Accretion 172,727 — 163,341 — $ (118,116 ) $ (207,447 ) $ 69,941 $ (148,477 ) Denominator: weighted average number of shares 11,500,000 8,205,556 11,500,000 11,500,000 Basic and diluted net profit (loss) per Class A ordinary share subject to possible redemption $ (0.01 ) $ (0.03 ) $ 0.01 $ (0.01 ) Non-redeemable Class A and B ordinary shares: Numerator: Net loss including Accretion $ (84,850 ) $ (82,100 ) $ (27,248 ) $ (43,316 ) Denominator: weighted average number of shares 3,355,000 3,247,445 3,355,000 3,355,000 Basic and diluted net loss per non-redeemable Class A and B ordinary share $ (0.03 ) $ (0.03 ) $ (0.01 ) $ (0.01 )

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Subsequent Events [Line Items]
SUBSEQUENT EVENTS		NOTE 16: SUBSEQUENT EVENTS a. b. In addition, in February 2022 the Company signed two amendments to the 2021 SAFE agreements according to which: (i) the discount rate was changed from 20% to 25% (ii) the valuation cap for purposes of calculating conversion price was reduced to $400,000 instead of $600,000, and (iii) the requirement to obtain subscription of convertible notes, as condition precedent for the transfer of funds under the 2021 SAFE, was reduced to $30,000 instead of $75,000. During June 2022, following the signing of the BCA and a subscription agreement under which a convertible note for the amount of $30,000 was subscribed for, the Company received the 2021 SAFE amount of $4,000. See also Note 7e. c. d. e. -owned Transaction Contemporaneously with the execution of the BCA, the Company, Moringa and an unaffiliated institutional investor (the “ Investor Securities Purchase Agreement The principal and interest amount are convertible at the lesser of: a) the fixed conversion price, of $11.00 per share, subject to adjustment, or (b) the greater of the Floor Price, which is initially $2.00 per share, or 90% of the market price at the date of exercise. The $30,000 purchase price payable by the Investor for the Investor Note and Financing Warrant will be placed in a controlled account, which is controlled by a person designated by Investor and who takes instructions only from the Investor. Funds may be taken out of the Controlled Account and paid to the Investor if either a) money is due to the Investor, generally as a result of the Company’s non -compliance On September
Moringa Acquisition Corp [Member]
Subsequent Events [Line Items]
SUBSEQUENT EVENTS	NOTE 9 — SUBSEQUENT EVENTS: The Company evaluated subsequent events and transactions that occurred after the balance sheet date and through the issuance date of these financial statements. The Company did not identify any subsequent events that would have required any adjustments or disclosures in the financial statements. Withdrawal of Promissory Note On July 26, 2022 the Company withdrew an additional $350 thousand under the Sponsor Promissory note.	NOTE 9 — SUBSEQUENT EVENTS: On January 27, 2022 the Company borrowed an additional $300 thousand from the promissory note given by the Sponsor.

Description of Organization and

Description of Organization and Business Operations	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Moringa Acquisition Corp [Member]
Description of Organization and Business Operations [Line Items]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1 — Description of Organization and Business Operations: a. Moringa Acquisition Corp (hereafter — the Company) is a blank check company, incorporated on September 24, 2020 as a Cayman Islands exempted company, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination (hereafter — the Business Combination). The Company is an emerging growth company, as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). All activity for the six months ended June 30, 2022, relates to the Company’s search for a target company, as well as attempts to consummate the Proposed Business Combination, as detailed in Note 1(f). The Company has selected December 31 as its fiscal year end. b. The Company’s sponsor is Moringa Sponsor, L.P., a Cayman exempted limited partnership (which is referred to herein, together with its wholly -owned The registration statement relating to the Company’s Public Offering was declared effective by the United States Securities and Exchange Commission (the “SEC”) on February 16, 2021. The initial stage of the Company’s Public Offering — the sale of 10,000,000 Units — closed on February 19, 2021 (hereafter — the Closing of the Public Offering). Upon that closing and the concurrent closing of the initial stage of the Private Placement (as defined below in Note 3). $100,000,000 was placed in a trust account (the “Trust Account”) (discussed in (c) below). On March 3, 2021, upon the full exercise by the underwriters of their over -allotment c. The proceeds held in the Trust Account will be invested in money market funds registered under the Investment Company Act and compliant with Rule 2a -7 The Company complies with the provisions of ASU 2016 -18 d. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering and the Private Placement are intended to be generally applied toward consummating an initial Business Combination. The initial Business Combination must occur with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding taxes payable on the income accrued in the Trust Account). There is no assurance that the Company will be able to successfully consummate an initial Business Combination. The Company, after signing a definitive agreement for an Initial Business Combination, will provide its public shareholders the opportunity to redeem all or a portion of their shares upon the completion of the initial Business Combination, either (i) in connection with a shareholder meeting called to approve the business combination or (ii) by means of a tender offer. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 following such redemptions. In such case, the Company would not proceed with the redemption of its public shares and the related initial Business Combination, and instead may search for an alternate initial Business Combination. If the Company holds a shareholder vote or there is a tender offer for shares in connection with an initial Business Combination, a public shareholder will have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account, calculated as of two days prior to the general meeting or commencement of the Company’s tender offer, including interest but less taxes payable. As a result, the Company’s Public Class A ordinary shares are classified as temporary equity upon the completion of the Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity”. Pursuant to the Company’s amended and restated memorandum and articles of association, if the Company is unable to complete the initial Business Combination within 24 months from the Closing of the Public Offering, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per -share The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to any Class B ordinary shares (as described in Note 7) held by them if the Company fails to complete the initial Business Combination within 24 months of the Closing of the Public Offering or during any extended time that the Company has to consummate an initial Business Combination beyond 24 months as a result of a shareholder vote to amend its amended and restated memorandum and articles of association. However, if the Sponsor or any of the Company’s directors or officers acquire any Class A ordinary shares, they will be entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the Initial Business Combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the Company after an initial Business Combination, the Company’s shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference over the ordinary shares. The Company’s shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that the Company will provide its shareholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, under the circumstances, and, subject to the limitations, described herein e. As of June 30, 2022, the Company had approximately $18 thousand of cash and an accumulated deficit of $1,154 thousand. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standard Codification 205 -40 Since its inception date and through the issuance date of these financial statements, the Company’s liquidity needs were satisfied through an initial capital injection from the Sponsor, followed by net Private Placement proceeds, as well as several withdrawals of the Sponsor promissory notes. Management has determined that it will need to continue to rely and is significantly dependent on future promissory notes or other forms of financial support (of which the Sponsor is not obligated to provide). Moreover, the Company has until February 19, 2023 (hereafter — the Mandatory Liquidation Date) to consummate an Initial Business Combination, whether the Proposed Business Combination or a different one. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company intends to complete an Initial Business Combination before the Mandatory Liquidation Date. However, there can be no assurance that the Company will be able to consummate any business combination ahead of the Mandatory Liquidation Date, nor will it be able to raise sufficient funds to complete an Initial Business Combination. These matters raise substantial doubt about the Company’s ability to continue as a going concern, for the subsequent twelve months following the issuance date of these financial statements. No adjustments have been made to the carrying amounts of assets or liabilities should the Company fail to obtain financial support in its pursuit to consummate an Initial Business Combination, nor if it is required to liquidate after the Mandatory Liquidation Date. f. On June 9, 2022, the Company entered into a Business Combination Agreement (hereafter — the Proposed Business Combination) with Holisto Ltd., a company organized under the laws of the State of Israel (hereafter — Holisto) and Holisto MergerSub, Inc., a Cayman Islands exempted company and wholly -owned Holisto is an Israeli company and a tech -powered The Business Combination Agreement and the transactions contemplated thereby have been unanimously approved by the boards of directors of Moringa and Holisto, and by the shareholders of Holisto. The foregoing description of the Proposed Business Combination does not purport to be complete. For further information and access to the full agreement and all other related agreements, refer to the Company’s Current Report on Form 8 -K	NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS: a. Moringa Acquisition Corp (hereafter — the Company) is a blank check company, incorporated on September 24, 2020 as a Cayman Islands exempted company, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination (hereafter — the Business Combination). The Company is an emerging growth company, as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). All activity for the period from September 24, 2020 (inception) through December 31, 2021 relates to the Company’s formation, its initial public offering (the “Public Offering”) described below and its search for a target company. The Company will generate interest income on proceeds held in the trust account derived from the Public Offering. The Company has selected December 31 as its fiscal year end. b. The Company’s sponsor is Moringa Sponsor, L.P., a Cayman exempted limited partnership (which is referred to herein, together with its wholly -owned The registration statement relating to the Company’s Public Offering was declared effective by the United States Securities and Exchange Commission (the “SEC”) on February 16, 2021. The initial stage of the Company’s Public Offering — the sale of 10,000,000 Units — closed on February 19, 2021 (hereafter — the Closing of the Public Offering). Upon that closing and the concurrent closing of the initial stage of the Private Placement (as defined below in Note 3). $100,000,000 was placed in a trust account (the “Trust Account”) (discussed in (c) below). On March 3, 2021, upon the full exercise by the underwriters of their over -allotment c. The proceeds held in the Trust Account will be invested in money market funds registered under the Investment Company Act and compliant with Rule 2a -7 The Company’s complies with the provisions of ASU 2016 -18 d. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering and the Private Placement are intended to be generally applied toward consummating an initial Business Combination. The initial Business Combination must occur with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding taxes payable on the income accrued in the Trust Account). There is no assurance that the Company will be able to successfully consummate an initial Business Combination. The Company, after signing a definitive agreement for an Initial Business Combination, will provide its public shareholders the opportunity to redeem all or a portion of their shares upon the completion of the initial Business Combination, either (i) in connection with a shareholder meeting called to approve the business combination or (ii) by means of a tender offer. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 following such redemptions. In such case, the Company would not proceed with the redemption of its public shares and the related initial Business Combination, and instead may search for an alternate initial Business Combination. If the Company holds a shareholder vote or there is a tender offer for shares in connection with an initial Business Combination, a public shareholder will have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account, calculated as of two days prior to the general meeting or commencement of the Company’s tender offer, including interest but less taxes payable. As a result, the Company’s Public Class A ordinary shares are classified as temporary equity upon the completion of the Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity.” Pursuant to the Company’s amended and restated memorandum and articles of association, if the Company is unable to complete the initial Business Combination within 24 months from the Closing of the Public Offering, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per -share The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to any Class B ordinary shares (as described in Note 7) held by them if the Company fails to complete the initial Business Combination within 24 months of the Closing of the Public Offering or during any extended time that the Company has to consummate an initial Business Combination beyond 24 months as a result of a shareholder vote to amend its amended and restated memorandum and articles of association. However, if the Sponsor or any of the Company’s directors or officers acquire any Class A ordinary shares, they will be entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the Initial Business Combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the Company after an initial Business Combination, the Company’s shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference over the ordinary shares. The Company’s shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that the Company will provide its shareholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, under the circumstances, and, subject to the limitations, described herein. e. Substantial Doubt about the Company’s Ability to Continue as a Going Concern As of December 31, 2021, the Company had approximately $39 thousand of cash and an accumulated deficit of $951 thousand. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standard Codification 205 -40 Business Combination. Since its inception date and through the issuance date of these financial statements, the Company’s liquidity needs were satisfied through an initial capital injection from the Sponsor, followed by net Private Placement proceeds, as well as several withdrawals of the Sponsor promissory notes. Management has determined that it will need to continue to rely and is significantly dependent on the unwithdrawn amounts under the outstanding Sponsor promissory notes, as well as on future promissory notes or other forms of financial support (of which the Sponsor is not obligated to provide). Moreover, the Company has until February 19, 2023 (hereafter — the Mandatory Liquidation Date) to consummate an Initial Business Combination. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. The Company intends to complete an Initial Business Combination before the Mandatory Liquidation Date. However, there can be no assurance that the Company will be able to consummate any business combination ahead of the Mandatory Liquidation Date, nor that they will be able to raise sufficient funds to complete an Initial Business Combination. These matters raise substantial doubt about the Company’s ability to continue as a going concern, for the subsequent twelve months following the issuance date of these financial statements. No adjustments have been made to the carrying amounts of assets or liabilities should the Company fail to obtain financial support in its search for an Initial Business Combination, nor if it is required to liquidate after the Mandatory Liquidation Date.

Public Offering and Private Pla

Public Offering and Private Placements	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Moringa Acquisition Corp [Member]
Public Offering and Private Placements [Line Items]
PUBLIC OFFERING AND PRIVATE PLACEMENTS	NOTE 3 — PUBLIC OFFERING AND PRIVATE PLACEMENTS: In the Initial Public Offering, the Company issued and sold 11,500,000 units (including 1,500,000 units sold at a second closing pursuant to the underwriters’ exercise of their over -allotment Each Unit (both those sold in the initial Public Offering and in the Private Placement) consists of one Class A ordinary share, $0.0001 par value, and one -half five Once the Public Warrants become exercisable, the Company may redeem them in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last reported sale price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30 -trading The Warrants included in the Units sold in the Private Placement (the “Private Warrants”) are identical to the Public Warrants except that the Private Warrants, for so long as they are held by the Sponsor, EarlyBirdCapital, Inc. or their respective affiliates: (1) will not be redeemable by the Company; (2) may not (including the Class A ordinary shares issuable upon exercise of those warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders thereof until 30 days after the completion of the Company’s initial Business Combination; (3) may be exercised by the holders thereof on a cashless basis; and (4) they (including the Class A ordinary shares issuable upon exercise thereof) are entitled to registration rights. The Company paid an underwriting commission of 2.0% of the gross proceeds of the Public Offering and the full exercise of the underwriters’ over -allotment	NOTE 3 — PUBLIC OFFERING AND PRIVATE PLACEMENTS: l. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted would have a material effect on the Company’s financial statements. In the Initial Public Offering, the Company issued and sold 11,500,000 units (including 1,500,000 units sold at a second closing pursuant to the underwriters’ exercise of their over -allotment Each Unit (both those sold in the initial Public Offering and in the Private Placement) consists of one Class A ordinary share, $0.0001 par value, and one -half five Once the Public Warrants become exercisable, the Company may redeem them in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last reported sale price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30 -trading The Warrants included in the Units sold in the Private Placement (the “Private Warrants”) are identical to the Public Warrants except that the Private Warrants, for so long as they are held by the Sponsor, EarlyBirdCapital, Inc. or their respective affiliates: (1) will not be redeemable by the Company; (2) may not (including the Class A ordinary shares issuable upon exercise of those warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders thereof until 30 days after the completion of the Company’s initial Business Combination; (3) may be exercised by the holders thereof on a cashless basis; and (4) they (including the Class A ordinary shares issuable upon exercise thereof) are entitled to registration rights. The Company paid an underwriting commission of 2.0% of the gross proceeds of the Public Offering and the full exercise of the underwriters’ over -allotment

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Moringa Acquisition Corp [Member]
Related Party Transactions [Line Items]
RELATED PARTY TRANSACTIONS	NOTE 4 — RELATED PARTY TRANSACTIONS: a. On December 9, 2020, the Company signed a promissory note, under which it could borrow up to a $300 thousand principal amount from the Sponsor. Amounts drawn by the Company under the note were to be used to cover finance costs and expenses related to its formation and capital raise. The entire unpaid balance was payable on the earlier of (i) March 31, 2021, or (ii) the date of a capital raise (i.e., the closing of the initial Public Offering). Any drawn amounts could be prepaid at any time. The promissory note did not bear any interest on the principal amount outstanding thereunder. The Company borrowed $170 thousand under the promissory note, $150 thousand prior to December 31, 2020 and an additional $20 thousand on February 2021. The total $170 thousand owed under the promissory note was repaid in March 2021, following the Closing of the Public Offering. On August 9, 2021 the Company and the Sponsor have entered into an additional Promissory Note agreement (hereafter — the Second Promissory Note), according to which the Company may withdraw up to $1 million to fulfil its ongoing operational needs or preparations towards an Initial Business Combination. The entire unpaid balance shall be payable on the earlier of (i) February 19, 2023, or (ii) the date on which the Company consummates its Initial Business Combination. Any drawn amounts could be prepaid at any time. The promissory note does not bear any interest on the principal amount outstanding thereunder. On December 23, 2021, the Company borrowed $300 thousand under the promissory note. During the six months ended June 30, 2022 the Company borrowed an additional $350 thousand from the promissory note given by the Sponsor. See Note 9 — Subsequent Events b. On December 16, 2020, the Company signed an agreement with the Sponsor, under which the Company shall pay the Sponsor a fixed $10 thousand per month for office space, utilities and other administrative expenses. The monthly payments under this administrative services agreement commenced on the effective date of the registration statement for the initial Public Offering and will continue until the earlier of (i) the consummation of the Company’s initial Business Combination, or (ii) the Company’s liquidation. As of June 30, 2022 the Company accrued for approximately $60 thousand with regards to this agreement, recorded under the Related Party balance. The composition of the Related Party balance as of June 30, 2022 and December 31, 2021 is as follows: June 30, December 31, 2021 In U.S. dollars Promissory note 650,000 300,000 Accrual for Administrative Services Agreement 10,000 10,000 660,000 310,000	NOTE 4 — RELATED PARTY TRANSACTIONS: a. On December 9, 2020, the Company signed a promissory note, under which it could borrow up to a $300 thousand principal amount from the Sponsor. Amounts drawn by the Company under the note were to be used to cover finance costs and expenses related to its formation and capital raise. The entire unpaid balance was payable on the earlier of (i) March 31, 2021, or (ii) the date of a capital raise (i.e., the closing of the initial Public Offering). Any drawn amounts could be prepaid at any time. The promissory note did not bear any interest on the principal amount outstanding thereunder. The Company borrowed $170 thousand under the promissory note, $150 thousand prior to December 31, 2020 and an additional $20 thousand on February 2021. The total $170 thousand owed under the promissory note was repaid in March 2021, following the Closing of the Public Offering. On August 9, 2021 the Company and the Sponsor have entered into an additional Promissory Note agreement (hereafter — the Second Promissory Note), according to which the Company may withdraw up to $1 million to fulfil its ongoing operational needs or preparations towards an Initial Business Combination. The entire unpaid balance shall be payable on the earlier of (i) February 19, 2023, or (ii) the date on which the Company consummates its Initial Business Combination. Any drawn amounts could be prepaid at any time. The promissory note does not bear any interest on the principal amount outstanding thereunder. On December 23, 2021, the Company borrowed $300 thousand under the promissory note. Refer to Note 9 — Subsequent Events b. On December 16, 2020, the Company signed an agreement with the Sponsor, under which the Company shall pay the Sponsor a fixed $10 thousand per month for office space, utilities and other administrative expenses. The monthly payments under this administrative services agreement commenced on the effective date of the registration statement for the initial Public Offering and will continue until the earlier of (i) the consummation of the Company’s initial Business Combination, or (ii) the Company’s liquidation. As of December 31, 2021 the Company accrued for approximately $10 thousand with regards to this agreement, recorded under the Related Party balance. The composition of the Related Party balance as of December 31, 2021 and 2020 is as follows: December 31, 2021 December 31, 2020 In U.S. dollars Promissory note 300,000 149,990 Legal fees paid by Sponsor — 120,000 Accrual for Administrative Services Agreement 10,000 — 310,000 269,990

General and Administrative

General and Administrative	12 Months Ended
	Dec. 31, 2021
Moringa Acquisition Corp [Member]
General and Administrative [Line Items]
GENERAL AND ADMINISTRATIVE	NOTE 8 — GENERAL AND ADMINISTRATIVE: The formation and other operating expenses for the years ended December 31, 2021 and 2020 are as follows: December 31, 2021 December 31, 2020 In U.S. dollars Legal expenses 353,368 145,000 Audit, bookkeeping and accounting 110,237 50,000 Professional services 78,411 — Management fees 109,295 — Insurance 281,147 — Other 11,475 860 943,933 195,860

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies, by Policy (Policies) [Line Items]
Basis of Presentation		a. The consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) as set forth in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). The consolidated financial statements include accounts of the Company’s wholly -owned
Use of estimates in the preparation of financial statements		b. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, valuation allowance for deferred tax assets, share -based The Company also considered the impact of COVID -19 -lived
Financial statements in U.S. dollars		c. A substantial portion of the Company’s financing activities, including equity transactions and cash investments, are incurred in U.S. dollars. The Company’s managements believes that the U.S. dollar is the currency of the primary economic environment in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar. The Company had determined the functional currency of its foreign subsidiaries is the U.S. dollar. The foreign operations are considered a direct and integral part or extension of the Company’s operations. The day -to-day Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are re -measured
Cash and cash equivalents		d. Cash and cash equivalents are short -term
Short-term deposits		e. -term Short -term -term
Property and equipment		f. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight -line % Computers and peripheral equipment 33 Office furniture and equipment 7
Intangible assets		g. Intangible assets are amortized on a straight -line
Impairment of long-lived assets		h. -lived Long -lived
Revenue recognition		i. Revenues are recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), which applies to all contracts with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: • • • • • At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. Company’s revenues are generated by providing online travel reservation services, which allows traveler using the Company’s platform to book hotel room reservation with hotel service providers on a stand -alone The Company’s contracts with hotel service providers provide the Company rates and availability information for rooms without transferring responsibility to deliver the service to the Company. Since the hotel service provider is the primarily responsible for providing the services, and the Company does not control the service provided by the hotel service provider to the traveler, the Company’s revenues are presented on a net basis in the consolidated statements of operations. The Company excludes all taxes assessed by a government authority, if any, from the measurement of transaction prices that are imposed on its travel related services or collected by the Company from travelers (which are therefore excluded from revenue). Cash collected from the travelers in advance includes the amounts owed to the hotel service providers and the Company’s commission. The Company records cash payment received from travelers as advance from travelers and deferred revenue. Advances from travelers represent the principal amount to be payable to the hotel service providers. Deferred revenue represents the Company’s estimated commission from the traveler. Payments to hotel service providers are generally due within 30 days of check -in The Company records the payments in advances from travelers and deferred revenues until the stayed night occurs, at which point the Company recognizes the revenue, net of amounts payable to hotel service providers, as this is when the Company’s performance obligation is satisfied. The balance of deferred revenues reflects the amount of the transaction price of the unsatisfied performance obligations at the end of reporting period. The Company anticipates that it will satisfy all of its performance obligation associated with the deferred revenue within a year of the balance sheet date. According to the Company’s agreement with some of its hotel service providers, the Company is entitled to commission based on the gross volume of revenue generated on the Company’s platform. Variable consideration is included in the transaction price if in the Company’s judgment it is probable that a significant future reversal of cumulative revenue under the contract will not occur. In certain transactions, the traveler has the option to cancel its booking before check -in The travelers pay the Company for the hotel room reservations when they book the reservation by payment to processing companies (“clearing companies”). The funds held by the clearing companies are classified as Funds held by clearing companies. Clearing fees are considered as fulfillment costs. The Company elected to use the practical expedient and recognize the costs as an expense when they occur since the amortization period of the assets that the Company otherwise would have recognized is one year or less. Similarly, the Company does not disclose the value of unsatisfied performance obligations since the original expected duration of the contracts is one year or less.
Cost of revenue		j. Cost of revenue primarily consist of payment processing charges, costs associated with third party data centers used to host the Company’s platform and the amortization of acquired technology (see also Note 5).
Research and development costs, net		k. Research and development expenses primarily consist of salaries and benefits related costs, third -party
Royalty bearing grants		l. Royalty bearing grants from the Israeli Innovation Authority (“IIA”) (previously known as the Office of the Chief Scientist) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a deduction from research and development expenses. The Company recognized participations in research and development as a reduction of research and development expenses for the years ended December 31, 2021 and 2020 in the amount of $321 and $471, respectively.
Advertising and Marketing Costs		m. Advertising and Marketing costs consisting of online advertising expenses to promote the Company’s brand and expensed (“consumer traffic acquisition cost”) as incurred. For the years ended December 31, 2021 and 2020, advertising and marketing expenses were $12,223 and $1,231, respectively.
Income tax		n. The Company accounts for income taxes in accordance with ASC 740, “Income Taxes.” ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value, if it is more likely than not that some portion of the entire deferred tax asset will not be realized. The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740, “Income Taxes.” Accounting guidance addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements, under which a company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.
Contingent Liabilities		o. The Company accounts for its contingent liabilities in accordance with ASC No. 450, “Contingencies.” A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2021 and 2020, the Company is not a party to any litigation that could have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.
Concentration of credit risks		p. Financial instruments that potentially subject the Company to credit risk primarily consist of cash and cash equivalents, short term deposits, funds held by clearing companies and receivables. For cash and cash equivalents, the Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits or similar limits in other jurisdictions. The Company places its cash and cash equivalents and short -term -quality For funds held by clearing companies, the Company is exposed to credit risk in the event of default by the clearing companies. The Company’s clearing companies consists of financial institutions with a high -quality For receivables, the Company is exposed to credit risk in the event of nonpayment to the extent of the amounts recorded on the accompanying consolidated balance sheets.
Fair value of financial instruments		q. The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three -tiered Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at measurement date. Level 2 — Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 — Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Cash and cash equivalents, short -term -term The fair value measurement of warrant liability (Note 7b, 7c and Note 9), SAFE (Note 7a), financial commitment assets (FCA) (Note 7b, 7c) and embedded derivative (Note 7b) are measured using unobservable inputs that require a high level of judgment to determine fair value, and thus are classified as Level 3 financial instruments. The Company estimates the fair value of warrant liability, SAFE, FCA and embedded derivative using the Binominal Option Pricing model, Monta Carlo Simulation model and Probability Weighted Expected Return Method, respectively. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.
Leases		r. The Company enters into various monthly operating leases for its operations. In certain lease agreements, the Company may receive renewals or expansion options, rent holidays, and other incentives. Lease expense is recognized over the term of the lease, starting when the Company takes possession of or controls the physical use of the property.
Severance pay		s. Pursuant to Section 14 of Israel’s Severance Compensation Law, 1963 (“Section 14”), all of the Company’s employees are included under this section and entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any liability for severance pay and the deposits under Section 14 are not recorded as an asset in the Company’s consolidated balance sheets. Severance cost amounted to $193 and $109 for the years ended December 31, 2021 and 2020, respectively.
Net profit (loss) per share		t. The Company computes net loss per share using the two -class -class -rata -converted The Company’s basic net loss per Ordinary Share is calculated by dividing net loss attributable to Ordinary Shares by the weighted -average -if-converted -dilutive
Share-based compensation		u. -based The Company accounts for share -based -Stock -based -pricing The Company recognizes compensation expenses for the value of its awards granted based on the straight -line -line The Company selected the Black -Scholes-Merton -options -pricing
Recent accounting pronouncements		v. As an “emerging growth company”, the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflects this election. In August 2020, the FASB issued ASU No. 2020 -06 -06 -06 -40 -06 -06
Recently Issued Accounting Pronouncements Not Yet Adopted		w. In February 2016, the FASB issued ASU 2016 -02 -of-use -term In June 2016, the FASB issued ASU No. 2016 -13
Moringa Acquisition Corp [Member]
Accounting Policies, by Policy (Policies) [Line Items]
Basis of Presentation	a. The Company’s unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the SEC for interim financial information and the instructions to Form 10 -Q	a. The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the SEC.
Use of estimates in the preparation of financial statements	j. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on the Company’s financial statements.	i. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on the Company’s financial statements.
Cash and cash equivalents	c. The Company considers as cash equivalents all short -term -term As of June 30, 2022, the Company held its cash and cash equivalents in an SVB bank account, and its Investments Held in Trust Account in Goldman Sachs money market funds. Money market funds are characterized as Level I investments within the fair value hierarchy under ASC 820.	c. The Company considers as cash equivalents all short -term -term As of December 31, 2021, the Company held its cash and cash equivalents in an SVB bank account, and its investments Held in Trust Account in Goldman Sachs money market funds. Money market funds are characterized as Level I investments within the fair value hierarchy under ASC 820.
Income tax	k. The Company accounts for income taxes in accordance with ASC 740, “Income Taxes (hereafter — ASC 740). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non -current The Company accounts for uncertain tax positions in accordance with ASC 740 -10 -10 -step	k. The Company accounts for income taxes in accordance with ASC 740, “Income Taxes (hereafter — ASC 740). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non -current The Company accounts for uncertain tax positions in accordance with ASC 740 -10 -10 -step
Net profit (loss) per share	e. The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net profit (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company applies the two -class -Redeemable -Redeemable In order to determine the net loss attributable to each class, the Company first considered the total profit (loss) allocable to both sets of shares. This is calculated using the total net profit (loss) less any Interest Earned on Investments Held in Trust Account. The accretion to redemption value of the Class A ordinary shares subject to possible redemption is fully allocated to the Class A ordinary shares subject to redemption. For each of the three and six months ended June 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into shares and then share in the earnings of the Company. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase an aggregate of 5,940,000 warrants in the calculation of diluted loss per share, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net profit (loss) per share is the same as basic net profit (loss) per share for each of the periods presented, and for each class.	e. The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company applies the two -class -redeemable As of December 31, 2021, the Company had outstanding warrants to purchase up to 5,940,000
Recent accounting pronouncements	l. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted would have a material effect on the Company’s financial statements.
Emerging Growth Company	b. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible, because of the potential differences in accounting standards used.	b. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible, because of the potential differences in accounting standards used.
Class A Ordinary Shares subject to possible redemption	d. As discussed in Note 1, all of the 11,500,000 -10-S99-3A Immediately upon the Closing of the Public Offering, the Company recognized the accretion from the offering costs allocated to the Class A Ordinary Shares subject to possible redemption, in an amount of $2,551,880.	d. As discussed in Note 1, all of the 11,500,000 -10-S99-3A Immediately upon the Closing of the Public Offering, the Company recognized the accretion from the offering costs allocated to the Class A Ordinary Shares subject to possible redemption. As of December 31, 2021, the shares of Class A Ordinary Shares subject to possible redemption reflected on the balance sheet are reconciled in the following table: As of December 31, 2021 Gross proceeds $ 115,000,000 Less: Portion of offering costs attributable to Class A shares subject to possible redemption $ (2,551,880 ) Plus: Accretion to redemption value $ 2,551,880 Class A ordinary shares subject to possible redemption $ 115,000,000
Concentration of credit risk	f. Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.	f. Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Public Warrant	g. The Company applied the provisions of ASC 815 -40	Public Warrants The Company applied the provisions of ASC 815 -40
Private Warrant liability	h. The Company accounts for the warrants in accordance with the guidance contained in Accounting Standards Codification 815 (“ASC 815”), “Derivatives and Hedging,” under which the warrants do not meet the criteria for equity treatment and must be recorded as derivative liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re -measurement -Scholes-Merton	g. The Company accounts for the warrants in accordance with the guidance contained in Accounting Standards Codification 815 (“ASC 815”), “Derivatives and Hedging,” under which the warrants do not meet the criteria for equity treatment and must be recorded as derivative liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re -measurement -Scholes-Merton
Financial instruments	i. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short -term	h. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short -term
Offering Costs		j. The Company complies with the requirements of the Accounting Standards Codification 340 -10-S99-1 Out of the total amount of offering costs, an amount of $7,599 was allocated to the Private Warrant Liability, and therefore charged as an expense.

Significant Accounting Polici_2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Significant Accounting Policies (Tables) [Line Items]
Schedule of straight-line method over the estimated useful lives of the assets	% Computers and peripheral equipment 33 Office furniture and equipment 7
Moringa Acquisition Corp [Member]
Significant Accounting Policies (Tables) [Line Items]
Schedule of class A ordinary shares subject to possible redemption	As of December 31, 2021 Gross proceeds $ 115,000,000 Less: Portion of offering costs attributable to Class A shares subject to possible redemption $ (2,551,880 ) Plus: Accretion to redemption value $ 2,551,880 Class A ordinary shares subject to possible redemption $ 115,000,000

Other Receivables and Prepaid_2

Other Receivables and Prepaid Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Schedule of other receivables and prepaid expenses	December 31, 2021 2020 Deposits* ) $ 588 $ 281 AII grants receivable 120 83 Prepaid expenses 1,188 119 Governmental institutions 116 25 Income to receive from hotel service providers 496 — Other 7 7 $ 2,515 $ 515 *)

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of composition of property and equipment	December 31, 2021 2020 Cost: Computers and peripheral equipment $ 103 $ 62 Office furniture and equipment 3 2 106 64 Accumulated depreciation: Computers and peripheral equipment 56 35 Office furniture and equipment 2 — 58 35 Depreciated cost $ 48 $ 29

Other Accounts Payable and Ac_2

Other Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Other Accounts Payable and Accrued Expenses [Abstract]
Schedule of other accounts payable and accrued expenses	December 31, 2021 2020 Paycheck protection program loan (1) $ — $ 21 Employees liabilities 468 253 Accrued expenses 273 37 Government institutions 4 5 $ 745 $ 316

Preferred Shares and Ordinary_2

Preferred Shares and Ordinary A Shares (Tables)	12 Months Ended
	Dec. 31, 2021
Preferred Shares And Ordinary AShares Abstract
Schedule of composition of preferred shares and ordinary A shares	December 31, December 31, Authorized Issued and outstanding Authorized Issued and outstanding Ordinary A Shares 74,220 65,814 74,220 65,814 Preferred A Shares 242,000 201,712 226,000 201,712 Preferred A1- Shares 14,000 13,423 14,000 13,423 Preferred A2- Shares 64,978 64,588 64,978 64,588 395,198 345,537 379,198 345,537

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Shareholders' Equity [Abstract]
Schedule of ordinary shares of the company confer on their holders voting rights	December 31, December 31, Authorized Issued and outstanding Authorized Issued and outstanding Ordinary Shares 604,780 119,977 620,780 119,977

Share Based Compensation (Table

Share Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Schedule of company’s share option plan activity	Number of options Weighted average exercise price Weighted average Remaining Contractual Life (Years) Aggregated Intrinsic Value (thousand) Outstanding as of January 1, 2020 25,724 $ 13.17 7.52 $ 76 Granted 7,401 $ 16.38 Exercised — $ — Forfeited (592 ) $ 17.35 Outstanding as of December 31, 2020 32,533 $ 13.82 7.8 $ 79 Granted 8,359 $ 17.35 Exercised — — Forfeited — — Outstanding as of December 31, 2021 40,892 $ 14.55 8.11 $ 372 Exercisable as of December 31, 2020 16,866 $ 11.73 7.75 $ 69 Exercisable as of December 31, 2021 26,517 $ 14.82 7.9 $ 163
Schedule of share options granted	2021 2020 Average Exercise price (Doller) 17.35 17.35 Expected volatility (%) 55.57% – 73.11% 80% Risk-free interest rate (%) 0.76% – 1.15% 0.49% – 0.69% Expected term (Years) 6.25 6 Expected dividend yield (%) — —
Schedule of share-based compensation expense	December 31, 2021 2020 Research and development, net $ 198 $ 168 Sales and marketing 73 59 General and administrative 192 186 $ 463 $ 413

Taxes on Income (Tables)

Taxes on Income (Tables)	12 Months Ended
	Dec. 31, 2021
Schedule of reconciliation of the tax benefit at the israeli statutory tax rate [Abstract]
Schedule of loss before income taxes	December 31 2021 2020 Domestic (Israel) $ (53,499 ) $ (3,759 ) Foreign 21 23 $ (53,478 ) $ (3,736 )
Schedule of income taxes	December 31 2021 2020 Current Domestic — — Foreign $ 6 $ 5 $ 6 $ 5
Schedule of amount of the Company’s deferred tax assets and liabilities	December 31, 2021 2020 Deferred tax asset Vacation accrual $ 24 $ 25 R&D deferred expenses 150 370 Intangible assets 63 18 Operating loss carryforward 3,633 1,693 Valuation allowance (3,840 ) (2,106 ) Total deferred tax asset net 30 — Deferred tax liability Long term loan (30 ) — Total deferred tax liability (30 ) — $ — $ —
Schedule of reconciliation of the tax benefit at the Israeli statutory tax rate	December 31, 2021 2020 Israel tax provision at statutory rate 23.0 % 23.0 % Non-deductible fair value valuations expenses (18.8 )% (0.6 )% Non-deductible stock compensation (0.2 )% (2.5 )% Change in valuation allowance (3.99 )% (19.8 )% Effective tax rate 0.01 % 0.1 %

Reporting Segments and Geogra_2

Reporting Segments and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2021
Reporting Segments and Geographic Information [Abstract]
Schedule of revenue disaggregated by geography, based on the billing address of the Company’s	December 31, 2021 2020 North America $ 14,160 $ 1,168 Other 908 36 $ 15,068 $ 1,204

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value Measurements (Tables) [Line Items]
Schedule of financial instruments that are measured at fair value on a recurring basis		December 31, Level 2020 2021 Financial liabilities: SAFE 3 $ 27,207 $ 325 Warrant liability 3 19,346 383 Financial assets: FCA 3 (203 ) — Reduced principal payment derivative 3 (16 ) — $ 46,334 $ 708
Schedule of key inputs used in the valuation of the SAFE		Input December 31, 2021 January 2021 Initial measurement Expected fair value per share of Preferred Shares $ 68.10 $ 54.94 Expected fair value per share of Ordinary Shares $ 38.53 $ 41.43 Probability of equity financing occurrence 5 % 50 % Probability of liquidity event occurrence 95 % 50 % Probability of dissolution occurrence 0 % 0 % Discount upon conversion to Preferred Share 10 % 10 % Time to liquidity (years) 0.5 1 Risk-Free Interest 0.19 % 0.1 % Underlying asset volatility 62.67 102.9 %
Schedule of key inputs used in the valuation of the investor warrant liability		Input December 31, 2021 December 31, 2020 September 30, Initial measurement Exercise price $ 36.91 $ 36.91 $ 36.91 Time to liquidation (years) 0.5 1 1.25 Risk free rate 0.19 % 0.1 % 0.01 % Expected Volatility 62.67 % 102.9 % 118.4 % Probability of initial public offering occurrence 95 % 50 % 50 % Probability of equity financing occurrence 5 % 50 % 50 % Input December 31, 2021 October 13, Initial Measurement March 25, Initial Measurement Exercise price $ 0.01 – $36.909 $ 0.01 $ 36.909 Time to liquidation (years) 0.5 0.22 0.75 Risk free rate 0.19% 0.05 % 0.06 % Expected Volatility 62.67% 59.65 % 93.96 % Probability of initial public offering occurrence 95% 60 % 50 % Probability of equity financing occurrence 5% 40 % 50 %
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]		SAFE Balance as of January 1, 2020 $ — Issuance of SAFE 325 Balance as of December 31, 2020 325 Issuance of SAFE 1,675 Change in fair value 25,207 Balance as of December 31, 2021 $ 27,207 Warrant Balance as of January 1, 2020 $ — Issuance of investors warrants 286 Change in fair value 97 Balance as of December 31, 2020 383 Issuance of Discount warrants 1,144 Change in fair value 17,819 Balance as of December 31, 2021 $ 19,346 Reduced Balance as of December 31, 2020 $ — $ — Issuance of FCA 256 16 Change in fair value (12 ) (* Exercise of FCA (65 ) — Balance as of December 31, 2021 $ 203 $ 16
Moringa Acquisition Corp [Member]
Fair Value Measurements (Tables) [Line Items]
Schedule of assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy	Level June 30, December 31, 2021 Assets: Money market funds held in Trust Account 1 115,179,099 115,006,372 Liabilities: Private Warrant Liability 3 28,804 160,341	Level December 31, 2021 Assets: Money market funds held in Trust Account 1 115,006,372 Liabilities: Private Warrant Liability 3 160,341
Schedule of quantitative information regarding level 3 fair value measurements inputs	June 30, December 31, Share price $ 10.0 10.0 Strike price $ 11.5 11.5 Volatility 50 % 50 % Risk-free interest rate 3.00 % 1.26 % Dividend yield 0.00 % 0.00 %	As of Share price $ 10.0 Strike price $ 11.5 Term (in years) 5.5 Volatility 50 % Risk-free interest rate 1.26 % Dividend yield 0.00 %
Schedule of derivative warrant liabilities		In U.S. dollars Value of private warrant liability measured with Level 3 inputs at Initial Measurement 342,684 Change in fair value of private warrant liability measured with Level 3 inputs (182,343 ) Transfer in/out — Value of warrant liability measured with Level 3 inputs at December 31, 2021 160,341

Loss per Share (Tables)

Loss per Share (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Loss per Share (Tables) [Line Items]
Schedule of basic and diluted net profit (loss) per share attributed to the ordinary shareholders		Year ended 2021 2020 Numerator: Net loss attributable to the Company Ordinary Shares $ 53,484 $ 3,741 Denominator: Weighted average stock used in computing net loss per share attributed to Ordinary Shares, basic and diluted 87,487 65,639 Net loss per share attributable to Ordinary Shares, basic and diluted: $ (611.33 ) $ (56.99 )
Schedule of diluted net loss per shares attributable to ordinary shareholders		Year ended 2021 2020 Restricted Ordinary Shares 23,116 41,608 Preferred Shares 279,723 279,723 Ordinary A Share 65,814 65,814 Warrant liability 37,374 14,383 SAFE 51,989 8,448 Outstanding share options 40,892 32,533 Total 498,908 442,509
Moringa Acquisition Corp [Member]
Loss per Share (Tables) [Line Items]
Schedule of basic and diluted net profit (loss) per share attributed to the ordinary shareholders	Six months ended Three months ended 2022 2021 2022 2021 Net profit (loss) $ (202,966 ) $ (289,547 ) $ 42,693 $ (191,793 ) Accretion to Class A ordinary shares subject to possible redemption to redemption amount (“Accretion”) (172,727 ) — (163,341 ) — Net loss including Accretion $ (375,693 ) $ (289,547 ) $ (120,648 ) $ (191,793 ) Class A ordinary shares subject to possible redemption: Numerator: Net loss including Accretion $ (290,843 ) $ (207,447 ) $ (93,400 ) $ (148,477 ) Accretion 172,727 — 163,341 — $ (118,116 ) $ (207,447 ) $ 69,941 $ (148,477 ) Denominator: weighted average number of shares 11,500,000 8,205,556 11,500,000 11,500,000 Basic and diluted net profit (loss) per Class A ordinary share subject to possible redemption $ (0.01 ) $ (0.03 ) $ 0.01 $ (0.01 ) Non-redeemable Class A and B ordinary shares: Numerator: Net loss including Accretion $ (84,850 ) $ (82,100 ) $ (27,248 ) $ (43,316 ) Denominator: weighted average number of shares 3,355,000 3,247,445 3,355,000 3,355,000 Basic and diluted net loss per non-redeemable Class A and B ordinary share $ (0.03 ) $ (0.03 ) $ (0.01 ) $ (0.01 )

Related Party Transactions (Tab

Related Party Transactions (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Moringa Acquisition Corp [Member]
Related Party Transactions (Tables) [Line Items]
Schedule of composition of the related party balance	June 30, December 31, 2021 In U.S. dollars Promissory note 650,000 300,000 Accrual for Administrative Services Agreement 10,000 10,000 660,000 310,000	December 31, 2021 December 31, 2020 In U.S. dollars Promissory note 300,000 149,990 Legal fees paid by Sponsor — 120,000 Accrual for Administrative Services Agreement 10,000 — 310,000 269,990

General and Administrative (Tab

General and Administrative (Tables)	12 Months Ended
	Dec. 31, 2021
Moringa Acquisition Corp [Member]
General and Administrative (Tables) [Line Items]
Schedule of formation and other operating expenses	December 31, 2021 December 31, 2020 In U.S. dollars Legal expenses 353,368 145,000 Audit, bookkeeping and accounting 110,237 50,000 Professional services 78,411 — Management fees 109,295 — Insurance 281,147 — Other 11,475 860 943,933 195,860

General (Details)

General (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
Accounting Policies [Abstract]
Accumulated deficit	$ 64,078
Operating losses	9,227
Negative cash from operating activities	$ 5,013

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Significant Accounting Policies (Details) [Line Items]
Research and development expenses		$ 321	$ 471
Advertising and marketing expenses		$ 12,223	1,231
Deposit rate percentage		8.33%
Severance cost		$ 193	$ 109
Moringa Acquisition Corp [Member]
Significant Accounting Policies (Details) [Line Items]
Share amount (in Shares)	11,500,000	11,500,000
Purchase shares (in Shares)	5,940,000	5,940,000
Federal depository insurance coverage	$ 250,000	$ 250,000
Incurred offering costs		334,345
Underwriter discount		2,300,000
Remaining amount		$ 7,599
Percentage of tax benefit	50%	50%
Shares subject to possible redemption	$ 2,551,880
Short Term Deposits [Member]
Significant Accounting Policies (Details) [Line Items]
Weighted average annual rate		0.01%	0.01%

Significant Accounting Polici_4

Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets	Dec. 31, 2021
Computers and Peripheral Equipment [Member]
Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets [Line Items]
Property, Plant and Equipment, Salvage Value, Percentage	33%
Office furniture and equipment [Member]
Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets [Line Items]
Property, Plant and Equipment, Salvage Value, Percentage	7%

Other Receivables and Prepaid_3

Other Receivables and Prepaid Expenses (Details) - Schedule of other receivables and prepaid expenses - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Schedule Of Other Receivables And Prepaid Expenses Abstract
Deposits	[1]	$ 588	$ 281
AII grants receivable		120	83
Prepaid expenses		1,188	119
Governmental institutions		116	25
Income to receive from hotel service providers		496
Other		7	7
Total		$ 2,515	$ 515
[1]As part of the Company’s agreement with certain hotel service providers, the Company provided a cash deposit to the hotel service provider as a guarantee for its transactions with the travelers.

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation expenses	$ 23	$ 17

Property and Equipment, Net (_2

Property and Equipment, Net (Details) - Schedule of composition of property and equipment - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Cost:
Cost	$ 106	$ 64
Accumulated depreciation:
Accumulated depreciation	58	35
Depreciated cost	48	29
Computers and peripheral equipment [Member]
Cost:
Cost	103	62
Accumulated depreciation:
Accumulated depreciation	56	35
Office furniture and equipment [Member]
Cost:
Cost	3	2
Accumulated depreciation:
Accumulated depreciation	$ 2

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Thousands		12 Months Ended
	Jul. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Net of acquisition cost	$ 896
Amortized period		3 years
Amortization expense		$ 299	$ 124

Other Accounts Payable and Ac_3

Other Accounts Payable and Accrued Expenses (Details) - Schedule of other accounts payable and accrued expenses - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Schedule Of Other Accounts Payable And Accrued Expenses Abstract
Paycheck protection program loan	[1]		$ 21
Employees liabilities		468	253
Accrued expenses		273	37
Government institutions		4	5
Total other accounts payable and accrued expenses		$ 745	$ 316
[1]See Note 7d regarding the United States Small Business Administration assistance to businesses and loans provided.

Long-Term Loans (Details)

Long-Term Loans (Details)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Oct. 13, 2021 USD ($) shares

May 06, 2020 USD ($)

Dec. 31, 2021 USD ($)

Jul. 31, 2021 USD ($)

Apr. 16, 2021 USD ($)

Mar. 31, 2021 USD ($)

Mar. 31, 2021 USD ($) shares

Jun. 30, 2021

Dec. 31, 2021 USD ($)

Oct. 13, 2021 ₪ / shares

Jan. 31, 2021 USD ($)

Dec. 31, 2020 USD ($)

Long-Term Loans (Details) [Line Items]

Existing investors total

$ 2,000,000

Advance received

$ 325,000

Future equity agreements, description

Pursuant to the applicable agreements, the SAFE automatically converts into Preferred Shares upon a future equity financing of at least $3,000 in which the Company sold such Preferred Shares. The number of Preferred Shares into which the SAFE would convert would be SAFE amount divided by the lower of (i) per-share price of the Preferred Share issued in the financing less a discount of 10%, and (ii) a per-share price obtained by dividing a valuation cap of $21,000 by the Company’s capitalization, on a fully diluted basis, immediately prior to the equity financing, excluding the SAFE, any other SAFEs and convertible loans (the “Company Capitalization” and the “Safe Price”, respectively); provided however, that in no event shall the conversion price be less than a per-share price obtained by dividing $19,500 by the Company Capitalization, unless the equity financing is made at a valuation which is lower than $19,500, in which event the SAFE will convert at the same per-share price as that determined in such equity financing. The number of shares that could be issued upon conversion SAFE is not limited.

Valuation capital amount

$ 600,000

Fair value adjustment

25,207,000

Debt Instrument fair value

$ 27,207,000

Borrowed working capital

$ 3,000,000

Interest rate

7%

11.50%

Principal amount percentage

3%

Additional loan amount

$ 1,000,000

$ 1,000,000

Warrant purchase (in Shares) | shares

20,591

Exercise price

$ 36,909

Exercised term year

7 years

Loan agreement, description

the Company raises more than $10,000 in an equity financing, the monthly repayment amount of the principal for 6 months will be reduced to 2% instead of 3%.

Proceeds received

$ 3,000,000

Fair value residual proceeds amount

$ 2,733,000

Borrowed additional funding

$ 1,500,000

Price per share (in New Shekels per share) | ₪ / shares

₪ 0.01

Capital, description

the Company does not consummate an equity capital raise reflecting a Company pre money valuation of at least $100,000 during the first 6 months following the agreement date, then, the Company shall grant Discount Capital an additional Warrant to purchase additional 1,200 Preferred A Shares at the par value of NIS 0.01 per share.

One-time fee

$ 200,000

Loans received

$ 21,000

$ 87,500

Loan payable years

5 years

Financial income

$ 109,000

Discount rate

20%

Preferred Shares [Member]

Long-Term Loans (Details) [Line Items]

Discount rate

20%

PPP loan [Member]

Long-Term Loans (Details) [Line Items]

Interest rate

1%

Initial Public Offering [Member]

Long-Term Loans (Details) [Line Items]

Valuation capital amount

$ 21,000,000

Preference A Shares [Member]

Long-Term Loans (Details) [Line Items]

Discount capital purchase (in Shares) | shares

2,400

Loan Agreement [Member]

Long-Term Loans (Details) [Line Items]

Exercised term year

7 years

New Additional Loan [Member]

Long-Term Loans (Details) [Line Items]

Loan amount

$ 1,500,000

Financing Agreement [Member]

Long-Term Loans (Details) [Line Items]

Proceeds received

1,500,000

Fair value residual proceeds amount

895,000

SAFE [Member]

Long-Term Loans (Details) [Line Items]

Valuation capital amount

$ 600,000

Discount rate

20%

Business Combination Agreement [Member]

Long-Term Loans (Details) [Line Items]

Company signed SAFEs amount

$ 4,000,000

Aggregate amount

$ 75,000,000

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) - USD ($)	1 Months Ended	6 Months Ended	12 Months Ended
	Aug. 20, 2021	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Commitments and Contingent Liabilities (Details) [Line Items]
Lease expenses			$ 118,000	$ 88,000
Royalty rate percentage			3%
Contingent obligation			$ 913,000	1,084,000
Loan agreement description			•        Once Discount Capital shall have utilized any portion of the Cushion Deposit, Company shall have 60 days from the receipt of the applicable utilization notice to make the Cushion Deposit whole again
Lien deposit amount			$ 50,000
Minimum [Member]
Commitments and Contingent Liabilities (Details) [Line Items]
Legal expanses	$ 50,000
Maximum [Member]
Commitments and Contingent Liabilities (Details) [Line Items]
Legal expanses	$ 75,000
Moringa Acquisition Corp [Member]
Commitments and Contingent Liabilities (Details) [Line Items]
Legal expanses			$ 353,368	145,000
Underwriters deferred discount percentage		3.50%	3.50%
Moringa Acquisition Corp [Member] | Public Offering [Member]
Commitments and Contingent Liabilities (Details) [Line Items]
Gross proceeds		$ 4,025,000	$ 4,025,000
Motor vehicles [Member]
Commitments and Contingent Liabilities (Details) [Line Items]
Lease expenses			$ 28,000	$ 25,000

Preferred Shares and Ordinary_3

Preferred Shares and Ordinary A Shares (Details)	12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 ₪ / shares	Oct. 13, 2021 $ / shares	Mar. 25, 2021 $ / shares	Dec. 31, 2020 $ / shares	Oct. 31, 2020 USD ($) shares	Oct. 31, 2020 ₪ / shares	Sep. 30, 2020 $ / shares
Preferred Shares and Ordinary A Shares (Details) [Line Items]
Interest rate	12%
Price per share rate	8%
Issued rate	50%
Outstanding rate	50%
Pre-money valuation	$ 369,089
Gross proceed	$ 16,000,000
Ordinary shares vote	one
Warrants (in Shares) | shares						14,838
Total consideration						$ 1,092,000
Issuance expenses	$ 806,000					$ 3,000
Warrant issuance expenses	$ 286,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in Dollars per share) | $ / shares	$ 36.91		$ 0.01	$ 36.909	$ 36.91			$ 36.91
Warrant [Member]
Preferred Shares and Ordinary A Shares (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in Dollars per share) | $ / shares	$ 36.9
Preferred A Shares [Member]
Preferred Shares and Ordinary A Shares (Details) [Line Items]
Exercisable warrants (in Shares) | shares	14,838					29,667
Preferred shares par value (in New Shekels per share) | ₪ / shares		₪ 0.01					₪ 0.01

Preferred Shares and Ordinary_4

Preferred Shares and Ordinary A Shares (Details) - Schedule of composition of preferred shares and ordinary A shares - shares	Dec. 31, 2021	Dec. 31, 2020
Preferred Shares and Ordinary A Shares (Details) - Schedule of composition of preferred shares and ordinary A shares [Line Items]
Authorized	395,198	379,198
Issued and outstanding	345,537	345,537
Ordinary A Shares [Member]
Preferred Shares and Ordinary A Shares (Details) - Schedule of composition of preferred shares and ordinary A shares [Line Items]
Authorized	74,220	74,220
Issued and outstanding	65,814	65,814
Preferred A Shares [Member]
Preferred Shares and Ordinary A Shares (Details) - Schedule of composition of preferred shares and ordinary A shares [Line Items]
Authorized	242,000	226,000
Issued and outstanding	201,712	201,712
Preferred A1- Shares [Member]
Preferred Shares and Ordinary A Shares (Details) - Schedule of composition of preferred shares and ordinary A shares [Line Items]
Authorized	14,000	14,000
Issued and outstanding	13,423	13,423
Preferred A2- Shares [Member]
Preferred Shares and Ordinary A Shares (Details) - Schedule of composition of preferred shares and ordinary A shares [Line Items]
Authorized	64,978	64,978
Issued and outstanding	64,588	64,588

Shareholders' Equity (Details)

Shareholders' Equity (Details) $ / shares in Units, $ in Thousands		1 Months Ended		6 Months Ended	12 Months Ended
	Mar. 03, 2021 shares	Feb. 19, 2021 shares	Nov. 20, 2020 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Oct. 13, 2021 ₪ / shares	Dec. 31, 2020 shares
Shareholders' Equity (Details) [Line Items]
Shareholders approved the reclassification					16,000
Ordinary shares issued					119,977		119,977
Preferred shares par value (in Dollars per share) | ₪ / shares						₪ 0.01
Moringa Acquisition Corp [Member]
Shareholders' Equity (Details) [Line Items]
Preferred shares authorized				5,000,000	5,000,000
Shares as compensation expenses (in Dollars) | $				$ 860	$ 860
Preferred shares par value (in Dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Moringa Acquisition Corp [Member] | Private Placement [Member]
Shareholders' Equity (Details) [Line Items]
Sale price per unit (in Dollars per share) | $ / shares					$ 10
Preferred A share [Member]
Shareholders' Equity (Details) [Line Items]
Preferred shares authorized					16,000
Class A Ordinary Shares [Member] | Moringa Acquisition Corp [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares issued			100,000
Ordinary shares par value (in Dollars per share) | $ / shares			$ 0.0001
Issuance of stock	380,000	11,500,000
Sale price per unit (in Dollars per share) | $ / shares				$ 10	$ 10
Temporary equity				11,500,000	11,500,000
Remaining permanent equity shares				480,000	480,000
Class A Ordinary Shares [Member] | Moringa Acquisition Corp [Member] | Public Offering [Member]
Shareholders' Equity (Details) [Line Items]
Consideration amount (in Dollars) | $				$ 115,000	$ 115,000
Class A Ordinary Shares [Member] | Moringa Acquisition Corp [Member] | Private Placement [Member]
Shareholders' Equity (Details) [Line Items]
Consideration amount (in Dollars) | $				$ 3,800	$ 3,800
Class B Ordinary Shares [Member] | Moringa Acquisition Corp [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares issued			2,875,000
Ordinary shares par value (in Dollars per share) | $ / shares			$ 0.0001
Total consideration (in Dollars) | $			$ 25
Ordinary share issued			2,875,00
Number of shares subject to forfeiture			375,000

Shareholders' Equity (Details)

Shareholders' Equity (Details) - Schedule of ordinary shares of the company confer on their holders voting rights - shares	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Ordinary Shares Of The Company Confer On Their Holders Voting Rights Abstract
Ordinary Shares, Authorized	604,780	620,780
Ordinary Shares, Issued and outstanding	119,977	119,977

Share Based Compensation (Detai

Share Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation (Details) [Line Items]
Repurchase agreement (in Dollars)			$ 1,300
Purchase of ordinary shares		44,946
Options vested percentage		25%
Dividend yield percentage			0%
Unrecognized compensation cost (in Dollars)			$ 891	$ 349
Weighted fair value of options granted (in Dollars per share)			$ 21,370	$ 13,410
Minimum [Member]
Share Based Compensation (Details) [Line Items]
Restricted percentage shares	25%
Maximum [Member]
Share Based Compensation (Details) [Line Items]
Restricted percentage shares	75%
Chief Executive Officer [Member]
Share Based Compensation (Details) [Line Items]
Repurchase of ordinary shares	42,003
Number of shares vested			28,877
Restricted shares			13,126
Chief Technology Officer [Member]
Share Based Compensation (Details) [Line Items]
Repurchase of ordinary shares	16,699
Number of shares vested			11,481
Restricted shares			5,218
Vice President [Member]
Share Based Compensation (Details) [Line Items]
Repurchase of ordinary shares	15,268
Number of shares vested			10,496
Restricted shares			4,772

Share Based Compensation (Det_2

Share Based Compensation (Details) - Schedule of company’s share option plan activity - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Company SShare Option Plan Activity Abstract
Weighted average exercise price Outstanding beginning	$ 13.82	$ 13.17
Weighted average Remaining Contractual Life (Years) Outstanding beginning		7 years 6 months 7 days
Aggregated Intrinsic Value (thousand) Outstanding beginning (in Dollars)	$ 79	$ 76
Weighted average exercise price Granted	$ 17.35	$ 16.38
Number of options Exercised (in Shares)
Weighted average exercise price Exercised
Number of options Forfeited (in Shares)
Weighted average exercise price Forfeited		17.35
Weighted average exercise price Outstanding Ending	$ 14.55	$ 13.82
Weighted average Remaining Contractual Life (Years) Outstanding Ending	8 years 1 month 9 days	7 years 9 months 18 days
Aggregated Intrinsic Value (thousand) Outstanding Ending (in Dollars)	$ 372	$ 79
Weighted average exercise price Exercisable Beginning		$ 11.73
Weighted average Remaining Contractual Life (Years) Exercisable Beginning		7 years 9 months
Aggregated Intrinsic Value (thousand) Exercisable Beginning (in Dollars)		$ 69
Weighted average exercise price Exercisable Ending	$ 14.82
Weighted average Remaining Contractual Life (Years) Exercisable Ending	7 years 10 months 24 days
Aggregated Intrinsic Value (thousand) Exercisable Ending (in Dollars)	$ 163

Share Based Compensation (Det_3

Share Based Compensation (Details) - Schedule of share options granted - Black-Scholes Option-Pricing Model [Member]	12 Months Ended
	Dec. 31, 2021 $ / shares
Share Based Compensation (Details) - Schedule of share options granted [Line Items]
Average Exercise price (Doller) (in Dollars per share)	$ 17.35
Expected volatility (%)	80%
Expected term (Years)	6 years
Expected dividend yield (%)
Minimum [Member]
Share Based Compensation (Details) - Schedule of share options granted [Line Items]
Risk-free interest rate (%)	0.49%
Maximum [Member]
Share Based Compensation (Details) - Schedule of share options granted [Line Items]
Risk-free interest rate (%)	0.69%

Share Based Compensation (Det_4

Share Based Compensation (Details) - Schedule of share-based compensation expense - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Share Based Compensation Expense Abstract
Research and development, net	$ 198	$ 168
Sales and marketing	73	59
General and administrative	192	186
Total share based compensation expense	$ 463	$ 413

Taxes on Income (Details)

Taxes on Income (Details)	12 Months Ended
	Dec. 31, 2021 USD ($)
Israeli [Member]
Taxes on Income (Details) [Line Items]
Corporate tax rate	23%
Net operating loss carryforwards (in Dollars)	$ 7,608
US subsidiary [Member]
Taxes on Income (Details) [Line Items]
U.S. federal tax rate	21%

Taxes on Income (Details) - Sch

Taxes on Income (Details) - Schedule of loss before income taxes - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Loss Before Income Taxes Abstract
Domestic (Israel)	$ (53,499)	$ (3,759)
Foreign	21	23
Total loss before income taxes	$ (53,478)	$ (3,736)

Taxes on Income (Details) - S_2

Taxes on Income (Details) - Schedule of income taxes - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Current
Domestic
Foreign	6	5
Total	$ 6	$ 5

Taxes on Income (Details) - S_3

Taxes on Income (Details) - Schedule of amount of the Company’s deferred tax assets and liabilities - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Deferred tax asset:
Vacation accrual	$ 24	$ 25
R&D deferred expenses	150	370
Intangible assets	63	18
Operating loss carryforward	3,633	1,693
Valuation allowance	(3,840)	(2,106)
Total deferred tax asset net	30
Deferred tax liability
Long term loan	(30)
Total deferred tax liability	(30)
Total

Taxes on Income (Details) - S_4

Taxes on Income (Details) - Schedule of reconciliation of the tax benefit at the Israeli statutory tax rate	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Reconciliation Of The Tax Benefit At The Israeli Statutory Tax Rate Abstract
Israel tax provision at statutory rate	23%	23%
Non-deductible fair value valuations expenses	(18.80%)	(0.60%)
Non-deductible stock compensation	(0.20%)	(2.50%)
Change in valuation allowance	(3.99%)	(19.80%)
Effective tax rate	0.01%	0.10%

Reporting Segments and Geogra_3

Reporting Segments and Geographic Information (Details) - Schedule of revenue disaggregated by geography, based on the billing address of the Company’s - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reporting Segments and Geographic Information (Details) - Schedule of revenue disaggregated by geography, based on the billing address of the Company’s [Line Items]
Revenue	$ 15,068	$ 1,204
North America [Member]
Reporting Segments and Geographic Information (Details) - Schedule of revenue disaggregated by geography, based on the billing address of the Company’s [Line Items]
Revenue	14,160	1,168
Other [Member]
Reporting Segments and Geographic Information (Details) - Schedule of revenue disaggregated by geography, based on the billing address of the Company’s [Line Items]
Revenue	$ 908	$ 36

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)			6 Months Ended	12 Months Ended
	Oct. 13, 2021	Mar. 25, 2021	Jun. 30, 2021	Dec. 31, 2021
Fair Value Measurements (Details) [Line Items]
Equity financing				$ 10,000
Principal amount percentage			3%
Fair value amount	$ 134,000	$ 122,000
Expire date		Jul. 13, 2021
FCA fair value		$ 65,000
Represents amount lower				$ 1,000
Minimum [Member]
Fair Value Measurements (Details) [Line Items]
Principal amount percentage				2%
Maximum [Member]
Fair Value Measurements (Details) [Line Items]
Principal amount percentage				3%

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of financial instruments that are measured at fair value on a recurring basis - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Financial assets:
Total	$ 708	$ 46,334
Level 3 [Member]
Financial liabilities:
SAFE 3	325	27,207
Warrant liability 3	383	19,346
Financial assets:
FCA 3		(203)
Reduced principal payment derivative 3		$ (16)

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of key inputs used in the valuation of the SAFE - USD ($)				1 Months Ended	12 Months Ended
	Oct. 13, 2021	Mar. 25, 2021	Sep. 30, 2020	Jan. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Key Inputs Used In The Valuation Of The Safe Abstract
Expected fair value per share of Preferred Shares $ (in Dollars)				$ 54.94	$ 68.1
Expected fair value per share of Ordinary Shares $ (in Dollars per share)				$ 41.43	$ 38.53
Probability of equity financing occurrence				50%	5%
Probability of liquidity event occurrence				50%	95%
Probability of dissolution occurrence				0%	0%
Discount upon conversion to Preferred Share				10%	10%
Time to liquidity (years)	2 months 19 days	9 months	1 year 3 months	1 year	6 months	1 year
Risk-Free Interest	0.05%	0.06%	0.01%	0.10%	0.19%	0.10%
Underlying asset volatility	59.65%	93.96%	118.40%	102.90%	62.67%	102.90%

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of key inputs used in the valuation of the investor warrant liability - $ / shares				1 Months Ended	12 Months Ended
	Oct. 13, 2021	Mar. 25, 2021	Sep. 30, 2020	Jan. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Exercise price $ (in Dollars per share)	$ 0.01	$ 36.909	$ 36.91		$ 36.91	$ 36.91
Time to liquidation (years)	2 months 19 days	9 months	1 year 3 months	1 year	6 months	1 year
Risk free rate	0.05%	0.06%	0.01%	0.10%	0.19%	0.10%
Expected Volatility	59.65%	93.96%	118.40%	102.90%	62.67%	102.90%
Probability of initial public offering occurrence	60%	50%	50%		95%	50%
Probability of equity financing occurrence	40%	50%	50%		5%	50%
Minimum [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Exercise price $ (in Dollars per share)					$ 0.01
Maximum [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Exercise price $ (in Dollars per share)					$ 36.909

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of summary of the changes in the fair value of our Level 3 financial instruments - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 30, 2020
SAFE [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance beginning
Issuance of SAFE		$ 1,675	325
Change in fair value		25,207
Balance ending		27,207	325
Warrant Liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance beginning
Issuance of investors warrants			286
Change in fair value		17,819	97
Balance ending		19,346	$ 383
Issuance of Discount warrants		1,144
FCA [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance beginning
Issuance of FCA		256
Change in fair value		(12)
Exercise of FCA		(65)
Balance ending		203
Reduced Principal Payment Derivative [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance beginning
Issuance of FCA		16
Change in fair value	[1]
Exercise of FCA
Balance ending		$ 16
[1]Represents an amount lower than $1.

Loss per Share (Details) - Sche

Loss per Share (Details) - Schedule of basic and diluted net profit (loss) per share attributed to the ordinary shareholders - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net loss attributable to the Company Ordinary Shares $	$ 53,484	$ 3,741
Denominator:
Weighted average stock used in computing net loss per share attributed to Ordinary Shares, basic and diluted	87,487	65,639
Net loss per share attributable to Ordinary Shares, basic and diluted: $	$ (611.33)	$ (56.99)

Loss per Share (Details) - Sc_2

Loss per Share (Details) - Schedule of diluted net loss per shares attributable to ordinary shareholders - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Diluted Net Loss Per Shares Attributable To Ordinary Shareholders Abstract
Restricted Ordinary Shares	23,116	41,608
Preferred Shares	279,723	279,723
Ordinary A Share	65,814	65,814
Warrant liability	37,374	14,383
SAFE	51,989	8,448
Outstanding share options	40,892	32,533
Total	498,908	442,509

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jul. 29, 2022	Jul. 26, 2022	Jun. 30, 2022	Jan. 27, 2022
Subsequent Events (Details) [Line Items]
Subsequent event, description		the discount rate was changed from 20% to 25% (ii) the valuation cap for purposes of calculating conversion price was reduced to $400,000 instead of $600,000, and (iii) the requirement to obtain subscription of convertible notes, as condition precedent for the transfer of funds under the 2021 SAFE, was reduced to $30,000 instead of $75,000.
Percentage of secured senior convertible note		5%
Senior notes		$ 30,000
Conversion price (in Dollars per share)		$ 11
Initially per shares (in Dollars per share)		$ 2
Exercise market price		90%
Purchase of price payable		$ 30,000
Warrant [Member]
Subsequent Events (Details) [Line Items]
Exercise price (in Dollars per share)		$ 11.5
Moringa Acquisition Corp [Member]
Subsequent Events (Details) [Line Items]
Legal fees		$ 353,368	$ 145,000
Sponsor promissory note							$ 300,000
Ordinary Share [Member]
Subsequent Events (Details) [Line Items]
Warrant (in Shares)		1,363,636
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Amount received	$ 1,060
Convertible note amount						$ 30,000
Received amount						$ 4,000
Subsequent Event [Member] | Moringa Acquisition Corp [Member]
Subsequent Events (Details) [Line Items]
Sponsor promissory note					$ 350,000
Subsequent Event [Member] | Preferred A Shares [Member]
Subsequent Events (Details) [Line Items]
Warrant (in Shares)				1,200
Holisto [Member]
Subsequent Events (Details) [Line Items]
Legal fees		$ 305,000
Legal fees Paid		$ 50,000

Description of Organization a_2

Description of Organization and Business Operations (Details) - Moringa Acquisition Corp [Member] - USD ($)			6 Months Ended	12 Months Ended
	Mar. 03, 2021	Feb. 19, 2021	Jun. 30, 2022	Dec. 31, 2021
Description of Organization and Business Operations (Details) [Line Items]
Trust account	$ 15,000,000
Net asset value per share (in Dollars per share)			$ 1	$ 1
Fair market value percentage				80%
Net tangible assets			$ 5,000,001	$ 5,000,001
Dissolution expenses			100,000	100,000
Cash			$ 18,000	39,000
Accumulated deficit				$ 951,000
Net assets held in trust account percentage			80%
Accumulated deficit			$ 1,154,000
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of units (in Shares)		10,000,000		11,500,000
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Trust account		$ 100,000,000
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Sale of units (in Shares)	1,500,000			1,500,000

Significant Accounting Polici_5

Significant Accounting Policies (Details) - Schedule of class A ordinary shares subject to possible redemption - Moringa Acquisition Corp [Member] - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Gross proceeds					$ 115,000,000
Less:
Portion of offering costs attributable to Class A shares subject to possible redemption					(2,551,880)
Plus:
Accretion to redemption value	$ 163,341		$ 172,727		2,551,880
Class A ordinary shares subject to possible redemption					$ 115,000,000

Public Offering and Private P_2

Public Offering and Private Placements (Details) - Moringa Acquisition Corp [Member] - USD ($)			6 Months Ended	12 Months Ended
	Mar. 03, 2021	Feb. 19, 2021	Jun. 30, 2022	Dec. 31, 2021
Public Offering and Private Placements (Details) [Line Items]
Offering price per share			$ 10	$ 10
Aggregate share (in Shares)			352,857	352,857
Aggregate units (in Shares)			27,143	27,143
Business combination term			5 years	5 years
Warrants price per share			$ 0.01	$ 0.01
Exceeds per share			$ 18	$ 18
Underwriting commission percentage			2%	2%
Underwriters' over-allotment (in Dollars)			$ 2,300,000	$ 2,300,000
Initial Public Offering [Member]
Public Offering and Private Placements (Details) [Line Items]
Sale of stock (in Shares)		10,000,000		11,500,000
Sold of units (in Shares)			11,500,000
Over-Allotment Option [Member]
Public Offering and Private Placements (Details) [Line Items]
Sale of stock (in Shares)	1,500,000			1,500,000
Sold of units (in Shares)			1,500,000
Private Placement [Member]
Public Offering and Private Placements (Details) [Line Items]
Price per share				$ 10
Price per share			$ 10
Class A Ordinary Shares [Member]
Public Offering and Private Placements (Details) [Line Items]
Price per share			10	10
Ordinary shares, par value			0.0001	0.0001
Share issued price per share				$ 11.5
Price per share			$ 11.5

Related Party Transactions (Det

Related Party Transactions (Details) - Moringa Acquisition Corp [Member] - USD ($) $ in Thousands	1 Months Ended			6 Months Ended	12 Months Ended
	Mar. 31, 2021	Feb. 28, 2021	Dec. 16, 2020	Jun. 30, 2022	Dec. 31, 2020	Jan. 27, 2022	Dec. 31, 2021	Dec. 23, 2021	Aug. 09, 2021	Dec. 09, 2020
Related Party Transactions (Details) [Line Items]
Promissory notes						$ 300
Administrative Services Agreement [Member]
Related Party Transactions (Details) [Line Items]
Administrative monthly payments			$ 10
Accrued agreement							$ 10
Related party balance				$ 60
Promissory Note [Member]
Related Party Transactions (Details) [Line Items]
Principal amount										$ 300
Promissory notes					$ 170			$ 300
Prior period additional					$ 150
Additional amount		$ 20
Repaid of promissory note	$ 170
Additional borrowed value				$ 350
Second Promissory Note [Member]
Related Party Transactions (Details) [Line Items]
Withdraw amount									$ 1,000

Related Party Transactions (D_2

Related Party Transactions (Details) - Schedule of composition of the related party balance - Moringa Acquisition Corp [Member] - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Promissory note	$ 300,000	$ 149,990
Legal fees paid by Sponsor		120,000
Accrual for Administrative Services Agreement	10,000
Total	$ 310,000	$ 269,990

Fair Value Measurements (Deta_6

Fair Value Measurements (Details) - Schedule of assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy - Moringa Acquisition Corp [Member] - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Level 1 [Member]
Assets:
Money market funds held in Trust Account	$ 115,179,099	$ 115,006,372
Level 3 [Member]
Liabilities:
Private Warrant Liability	$ 28,804	$ 160,341

Fair Value Measurements (Deta_7

Fair Value Measurements (Details) - Schedule of quantitative information regarding level 3 fair value measurements inputs - Moringa Acquisition Corp [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2022 $ / shares $ / item	Dec. 31, 2021 $ / shares $ / item
Fair Value Measurements (Details) - Schedule of quantitative information regarding level 3 fair value measurements inputs [Line Items]
Share price (in Dollars per share) | $ / shares	$ 10	$ 10
Strike price (in Dollars per Item) | $ / item	11.5	11.5
Term (in years)		5 years 6 months
Volatility	50%	50%
Risk-free interest rate	3%	1.26%
Dividend yield	0%	0%

Fair Value Measurements (Deta_8

Fair Value Measurements (Details) - Schedule of derivative warrant liabilities - Moringa Acquisition Corp [Member]	12 Months Ended
	Dec. 31, 2021 USD ($)
Fair Value Measurements (Details) - Schedule of derivative warrant liabilities [Line Items]
Value of private warrant liability measured with Level 3 inputs at Initial Measurement	$ 342,684
Change in fair value of private warrant liability measured with Level 3 inputs	(182,343)
Transfer in/out
Value of warrant liability measured with Level 3 inputs at December 31, 2021	$ 160,341

General and Administrative (Det

General and Administrative (Details) - Schedule of formation and other operating expenses - Moringa Acquisition Corp [Member] - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
General and Administrative (Details) - Schedule of formation and other operating expenses [Line Items]
Legal expenses	$ 353,368	$ 145,000
Audit, bookkeeping and accounting	110,237	50,000
Professional services	78,411
Management fees	109,295
Insurance	281,147
Other	11,475	860
Total	$ 943,933	$ 195,860

Related Party Transactions (D_3

Related Party Transactions (Details) - Schedule of composition of the related party balance - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Schedule Of Composition Of The Related Party Balance Abstract
Promissory note	$ 650,000	$ 300,000
Accrual for Administrative Services Agreement	10,000	10,000
Total	$ 660,000	$ 310,000

Fair Value Measurements (Deta_9

Fair Value Measurements (Details) - Schedule of assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy - Moringa Acquisition Corp [Member] - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Level 1 [Member]
Assets:
Money market funds held in Trust Account	$ 115,179,099	$ 115,006,372
Level 3 [Member]
Liabilities:
Private Warrant Liability	$ 28,804	$ 160,341

Fair Value Measurements (Det_10

Fair Value Measurements (Details) - Schedule of quantitative information regarding level 3 fair value measurements inputs - Moringa Acquisition Corp [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2022 $ / shares $ / item	Dec. 31, 2021 $ / shares $ / item
Fair Value Measurements (Details) - Schedule of quantitative information regarding level 3 fair value measurements inputs [Line Items]
Share price (in Dollars per share) | $ / shares	$ 10	$ 10
Strike price (in Dollars per Item) | $ / item	11.5	11.5
Volatility	50%	50%
Risk-free interest rate	3%	1.26%
Dividend yield	0%	0%

Net Profit (Loss) Per Share (De

Net Profit (Loss) Per Share (Details) - Schedule of basic and diluted net profit (loss) per share - Moringa Acquisition Corp [Member] - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Net Profit (Loss) Per Share (Details) - Schedule of basic and diluted net profit (loss) per share [Line Items]
Net profit (loss)	$ 42,693	$ (191,793)	$ (202,966)	$ (289,547)
Accretion to Class A ordinary shares subject to possible redemption to redemption amount (“Accretion”)	(163,341)		(172,727)
Net loss including Accretion	(120,648)	(191,793)	(375,693)	(289,547)
Numerator:
Net loss including Accretion	(93,400)	(148,477)	(290,843)	(207,447)
Accretion	163,341		172,727		$ 2,551,880
Total	$ 69,941	$ (148,477)	$ (118,116)	$ (207,447)
Denominator:
weighted average number of shares (in Shares)	11,500,000	11,500,000	11,500,000	8,205,556
Numerator:
Net loss including Accretion	$ (27,248)	$ (43,316)	$ (84,850)	$ (82,100)
Denominator:
weighted average number of shares (in Shares)	3,355,000	3,355,000	3,355,000	3,247,445
Class A Ordinary Shares [Member]
Denominator:
Basic and diluted net profit (loss) per Class A ordinary share subject to possible redemption (in Dollars per share)	$ 0.01	$ (0.01)	$ (0.01)	$ (0.03)
Class A and B Ordinary Shares [Member]
Denominator:
Basic and diluted net loss per non-redeemable Class A and B ordinary share (in Dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.03)

Net Profit (Loss) Per Share (_2

Net Profit (Loss) Per Share (Details) - Schedule of basic and diluted net profit (loss) per share (Parentheticals) - Moringa Acquisition Corp [Member] - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Class A Ordinary Shares [Member]
Net Profit (Loss) Per Share (Details) - Schedule of basic and diluted net profit (loss) per share (Parentheticals) [Line Items]
Basic and diluted net profit (loss) per Class A ordinary share subject to possible redemption (in Dollars per share)	$ 0.01	$ (0.01)	$ (0.01)	$ (0.03)
Class A and B Ordinary Shares [Member]
Net Profit (Loss) Per Share (Details) - Schedule of basic and diluted net profit (loss) per share (Parentheticals) [Line Items]
Basic and diluted net loss per non-redeemable Class A and B ordinary share	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.03)